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Abstract 
Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist. It is used in 
diverse clinical scenarios, including as an adjunct to clinical decision making for diagnosis, a real-time 
guide to procedures, and a predictor or measurement of treatment response. The aim of this European 
Respiratory Society task force was to produce a statement on thoracic ultrasound for pulmonologists 
using thoracic ultrasound within the field of respiratory medicine. The multidisciplinary panel performed 
a review of the literature, addressing major areas of thoracic ultrasound practice and application. The 
selected major areas include equipment and technique, assessment of the chest wall, parietal pleura, 
pleural effusion, pneumothorax, interstitial syndrome, lung consolidation, diaphragm assessment, 
intervention guidance, training, and the patient perspective. Despite the growing evidence supporting 
the use of thoracic ultrasound, the published literature still contains a paucity of data in some important 
fields. Key research questions for each of the major areas were identified, which serve to facilitate 
future multi-centre collaborations and research to further consolidate an evidence-based use of thoracic 
ultrasound, for the benefit of the many patients being exposed to clinicians using thoracic ultrasound. 
  
Introduction 
Thoracic ultrasound (TUS) is increasingly considered an essential tool for the pulmonologist [1-3]. 
Although this technique was for many years considered “of no use” in the lung, many decades of 
research have demonstrated high clinical utility in a number of areas of pulmonary disease. While the 
technique of TUS originated with radiologists, it is increasingly being used by pulmonologists “at the 
bedside”, and in this context is used with several potential aims. These include as an adjunct to clinical 
decision making for diagnosis, as a real-time guide to procedures, and as a predictor or measurement of 
treatment response [1, 2, 4-6].  
This European Respiratory Society (ERS) statement has been written in light of the growing evidence 
behind the use of TUS across a broad range of respiratory disease areas, as a summary of the evidence 
to clinicians who wish to understand the current rationale and state of the art of this technique.  An 
evidence-based approach has been used throughout, addressing major areas of TUS practice and 
application. These include chapters on required equipment and technique, assessment of the chest wall, 
parietal pleura, pleural effusion, pneumothorax, the utility of ultrasound (US) in diffuse lung 
parenchymal diseases, diaphragm assessment, intervention guidance, and finally suitable training in 
TUS.  
We have highlighted areas of potential future research, as suggested by the current state of the 
evidence, at the end of each topic, and hope that this will lead to further definitive studies which will 
further improve our diagnostic and treatment armamentarium and benefit our patients.  
Methods 
The task force was comprised of clinicians with internationally recognised expertise in TUS. In order to 
reflect the multidisciplinary use of TUS, the expert group included pulmonologists and relevant experts 
from other specialties (e.g. radiology, emergency medicine, intensive care, thoracic surgery, paediatrics). 
This group was supplemented with young ERS members with TUS experience, and representatives of the 
European Lung Foundation (ELF). An ERS methodologist provided feedback on research strategy, 
evidence and statement synthesis, and oversight of the task force process. 
The task force was initiated in December 2018 and comprised one face-to-face meeting, regular 
telephone conferences and e-mail correspondence.  Initially, the task force established the overall scope 
and aim of the statement. It was agreed to limit the statement to the general use of TUS in the context 
of the clinical use by a pulmonologist. The members then agreed on a list of core topics which was to be 
addressed in the final statement.  
A group of task force members with a designated topic leader was assigned to each topic and was 
responsible for development of a search strategy, evidence synthesis, and writing of an initial topic 
section for the statement. MEDLINE and Scopus databases were used for the literature searches, with 
inclusion of additional studies identified by individual task force members. An ELF representative was 
assigned to the write a section on the topic “patient perspectives”. The search terms for each topic are 
provided in the Appendix. The topic leader identified and used relevant studies and knowledge of 
current clinical practice to make an initial topic draft which the topic group then reviewed until a 
proposed final topic section had been completed. In addition to evidence synthesis, each group was 
given the task of identifying major gaps in the current evidence and provide key areas for future TUS 
research. The findings from the literature regarding the “patient perspectives” topic were shared with 
patients who had experience of TUS to identify additional perspectives. 
Using the proposed topic sections, the task force chairmen comprised a first draft of the statement 
manuscript. Task force members then provided comments and suggestions in the making of the final 
manuscript based on the draft. The final version of the manuscript was reviewed and approved by all 
task force members. The statement provides an overview of the evidence and current clinical practice 
for general TUS performed by pulmonologists but does not provide recommendations for clinical 
practice.  
According to ERS policies task force members disclosed potential conflict of interests at the beginning of 




1. Equipment and technique 
Overview of the evidence and current practice 
When compared to other forms of clinical US with an established clinical tradition or more narrow 
clinical indication, international consensus publications regarding the equipment and technique used for 
TUS are scarce [1, 3, 7]. The first international consensus paper on point-of-care lung US provides some 
essential basic definitions and terminology [1]. However, when compared to recommendations on 
point-of-care cardiac US, a general recommendation regarding equipment and technique is not provided 
[8]. This reflects current clinical practice, in which choice of TUS scanning protocol, equipment and 
technique varies between specialties and countries. Numerous different protocols, techniques and use 
of different equipment have been assessed and validated in prospective diagnostic accuracy studies [6, 
9-29]. Studies directly assessing or comparing different TUS equipment or techniques are fairly limited. 
These studies have however demonstrated that factors such as choice of US machine (e.g. high-end, 
hand-held), protocol, transducer and patient positioning have a potential clinical impact [30-39]. Even 
though studies have addressed important factors, it is not possible to derive a universal and evidence-
based TUS approach for any given clinical scenario. Apart from the examination itself, the COVID-19 
pandemic has increased awareness of US operators in ensuring necessary safety precautions, specifically 
regarding cleansing of equipment and appropriate infection control [40].  
Table 1. Recommendations for future research: Equipment and technique 
Area of future research Question 
Protocol Which specific TUS protocol is optimal for a 
given clinical setting or problem? 
US equipment and software What is the optimal choice of US equipment 
and software in a given clinical setting or 
problem? 
Inter- and intra-observer variance What are the inter- and intra-observer 
variance for the specific protocols and 
equipment in various clinical settings?  
 
Conclusions 
Many different approaches and techniques have been described and validated. Comparative studies 
directly comparing different TUS approaches are limited. Given the many clinical settings and 
indications, a “one size fits all” TUS approach is not feasible or meaningful. There remains a need to 
reach consensus on a general TUS principles and to determine the optimal approach for more specific 
clinical problems or settings. 
2. Chest wall and parietal pleura 
Chest wall soft tissues 
On TUS, the intercostal muscle and fascia are visualised as echogenic layers under the subcutaneous 
tissue (fig. 1). TUS can be used to identify and characterise superficial chest wall lesions, although 
generally cross-sectional imaging modalities, such as computed tomography (CT) and magnetic 
resonance imaging (MRI) are more accurate [41].    
Visceral and parietal pleura 
Below the intercostal muscle, the visceral and parietal pleura are visualised as an echogenic ‘pleural line’ 
visible between and deep to the ribs (fig 1.). In healthy individuals, the pleural line slides parallel to the 
chest wall during respiration generating a sparkling appearance (‘lung sliding’) and may move in 
synchrony with cardiac pulsation (‘lung pulse’).  Lung sliding can be confirmed using M-mode, which 
gives a characteristic ‘seashore’ sign [1]. 
Hypoechoic parietal pleural thickening may mimic a pleural effusion on US and use of colour Doppler 
may help to differentiate these conditions, with fluid showing disordered colour flow unlike static, solid 
pleural thickening. Benign pleural tumours such as fibromas and lipoma are relatively rare, are usually 
round or ovoid in shape, hypoechoic and homogeneous and do not infiltrate surrounding structures (fig. 
1) [42].  Asbestos-related pleural plaques have a distinctive TUS appearance and are hypoechoic, 
elliptical, and smoothly limited foci; if calcified, they produce prominent acoustic shadows [42].  
Malignant pleural nodularity is a more common finding and can be seen as irregular, well-circumscribed, 
often heterogeneous lumps arising from the parietal pleura and distorting the normal contour of the 
visceral pleura. They may be associated with a pleural effusion or chest wall/rib invasion [43]. 
TUS has been evaluated in the identification of the presence and degree of chest wall invasion of 
intrathoracic malignancies, and in one study was shown to have a higher sensitivity than CT [44]. The 
absence of pleural motion next to a peripheral lung lesion may identify parietal pleural invasion thus 
refining radiological staging.  In one study, the use of qualitative and quantitative colour Doppler 
sonography was more sensitive and specific than CT for predicting chest wall invasion by lung tumours 
[45]. 
Ribs 
The ribs are seen as superficial, curvilinear structures, which completely reflect the US wave, resulting in 
posterior acoustic shadowing (rib shadows) (fig. 1).  If an US probe is placed along the long axis of a rib, 
the cortex of the bone is visible as a static, bright, echogenic line. When a cortical fracture is present, 
this line is disrupted by a step or gap and reverberation echoes occur at the point of the fracture (known 
as ‘the lighthouse phenomenon’) (fig. 1). Fractures may be associated with a visible haematoma, a 
reactive pleural effusion or subpleural parenchymal changes from lung contusion. A recent systematic 
review suggests that TUS is more sensitive than chest radiography (CXR) in diagnosing rib fractures; 
however it can be painful and time-consuming, may be technically challenging in obese patients and the 
first ribs and retroscapular areas are incompletely visible. TUS may have a useful role in assessing focal 
areas of rib pain [46].  
Metastatic disease to the ribs causes destruction of the bone cortex, resulting in an irregular cortical 
appearance and loss of the usual rib shadows. In this instance, the infiltrated bone structure may be 
more visible and appear hypoechoic and heterogenous [47]. 
Intercostal muscles 
The intercostal muscles can be directly visualised between the ribs. Even though the role of TUS 
assessment of intercostal muscle function is yet to be established, studies have reported several 
possible clinical implications. In a study by Wallbridge et al. muscle thickness and echogenicity was 
found to correlate with spirometry assessment of severity in patients with chronic obstructive 
pulmonary disease (COPD)[48]. Intercostal muscle assessment has also been reported as a possible tool 
for assessing respiratory workload in mechanically ventilated patients and for predicting failure of 
spontaneous breathing trials after supported ventilation [49-51].      
Intercostal vessels 
Distal to the apex of the rib posteriorly, the intercostal vessels run in the subcostal groove, but their 
course may be tortuous particularly in the elderly. Colour flow Doppler, using a linear probe allows good 
visualisation of the vessels and in theory may reduce vascular injury during pleural intervention [52].  
However, the technique is operator and experience dependent and its reliability and accuracy has been 
questioned.   
Table 2. Recommendations for future research: Chest wall and parietal pleura  
Area of future research Question 
Trauma patients What is the role for TUS in the diagnosis of 
rib fractures? 
Malignancy What is the accuracy of TUS for pleural and 
chest wall invasion by peripheral lung 
cancers? 
Invasive procedures Does TUS of intercostal vessels actually 
reduce frequency of vessel injury? 
 
Conclusions 
TUS is a useful clinical tool for assessing the chest wall and parietal pleura.  Further studies are required 
to ascertain its clinical utility and impact in specific clinical scenarios.  
3. Pleural effusion  
TUS has been used to assess suspected pleural effusion for at least 40 years [53-55]. Recently, a desire 
for better identification, classification and quantification of pleural fluid, coupled with rapid 
improvements in technology, has driven the widespread adoption of TUS amongst many 
pulmonologists. Indeed, being able to locate fluid with US to guide intervention is now seen as a core 
skill for trainees [56]. 
Benefits of TUS over other modalities 
Basic, grey-scale TUS can identify much smaller volumes of fluid in comparison to other modalities, 
particularly CXR [57, 58]. It can do so reliably (meta-analysis data suggests a sensitivity of 93% and 
specificity of 96%) [59] in real-time at the bedside, with very high spatial resolution. The addition of 
colour Doppler may enhance assessment and improve differentiation of fluid from pleural thickening 
[60, 61].  
Point-of-care versus diagnostic imaging 
TUS is most commonly used as a point-of-care test to guide intervention for pleural effusions and there 
is strong evidence to suggest this improves safety and can guide management decisions [62-64].  With 
sufficient experience, more formal diagnostic imaging is possible. While the ultrasonographic 
appearance of the fluid in itself cannot be considered diagnostic of the underlying disease, other typical 
TUS findings may help support a diagnosis (e.g. irregular nodularity on the diaphragm in malignant 
pleural effusion) (fig. 2) [65]. 
Visualising fluid and estimating volume 
Pleural effusions are most completely imaged with low frequency US transducers which allow for better 
understanding of fluid location and depth relative to deeper organs. Such frequencies are usually 
associated with curvilinear (typically 2-6 MHz) or sector (typically 1-3 MHz) probes. [66] Care must be 
taken with image processing settings, particularly gain, as these may adversely influence interpretation 
of fluid characteristics if incorrect [67]. The following four categories, described by Yang et al. are 
commonly referred to when describing effusion appearance: anechoic,  complex non-septated, complex 
septated, and homogeneous echogenic (fig. 2)[68].  
Freely mobile fluid will often be most easy to scan with the probe placed on the posterior or lateral 
chest, with the patient sat upright to allow the effusion to pool inferiorly. In some circumstances, 
particularly in those who are recumbent on the intensive care unit, finding a suitable window may be 
more challenging. 
Basic estimations of fluid volume may be useful when trying to quantify treatment effects of non-
invasive therapy (such as diuretics for cardiac impairment) or when deciding whether to drain an 
effusion in a ventilated patient. Several simple equations have been devised to try and estimate fluid 
volume based on US appearances. Hassan et al. tested the accuracy of five of these in 46 patients, and 
determined the most accurate to involve the total height of the effusion (H) in cm and the distance from 
bottom of the lung to apex of the diaphragm (C) in cm: 
  (H+C) cm x 70 ml/cm = effusion volume ml 
 This calculation was found to have an 83% accuracy when predicting fluid volume [69]. 
Transudative disease versus exudative disease 
Although not specific, presentation with bilateral effusions or associated ascites are strongly associated 
with transudates [70, 71]. Effusions due to transudative processes tend to have lower concentrations of 
complex molecules, particularly proteins. On TUS, this often makes the fluid appear anechoic (fig. 2). 
This is not specific, however, with one series finding 14% of transudates to be echogenic [72]. By 
contrast, effusions which are exudates will almost always demonstrate echogenicity, complexity, or both 
[72-74].  There is also a strong correlation between ‘swirling’ and exudative processes, although again 
this is not a specific sign (fig. 2)[75-77]. 
Features of malignant disease 
There are no effusion features specific to malignant effusions although many will show exudate 
characteristics and swirling is also frequently noted [74, 75].  Anechoic appearances have been 
described in around 10% of cases [65]. Chronicity or more active malignancy may lead to the formation 
of fibrous septations and/or loculation [74]. The presence of an effusion in conjunction with pleural or 
diaphragmatic nodularity is almost always indicative of malignancy, although such signs may be subtle 
(fig. 2) [65]. 
Features of pleural infection 
Septation and/or loculation are suggestive of pleural infection requiring drainage in the appropriate 
clinical context (fig. 2) [63], and may indicate a greater likelihood of failing fibrinolytic therapy [78]. One 
small series described the “suspended microbubble” sign and found it to be highly sensitive and specific 
for frank empyema [79]. In tuberculous effusions, complex septated appearances have a positive 
predictive value of 84% at 12 months for residual pleural thickening [80]. For ‘simple’ parapneumonic 
effusions, no fluid signs are known to be associated with eventual need for treatment [81] but in a small 
paediatric series, a greater degree of echogenicity was associated with positive fluid culture, the need 
for more procedures, and longer duration of treatment [82].  
Imaging atelectatic lung within fluid 
The presence of even a relatively small effusion may cause compressive atelectasis, and this allows the 
non-aerated lung to be assessed by US [83]. Atelectatic segments have been described as resembling a 
‘J’ or a ‘hockey stick’ (fig. 2), and within them it may be possible to appreciate malignant lesions. There is 
also evidence to suggest that M-mode measurements taken from atelectatic lung may be predictive of 
non-expandable lung [84].   
Table 3. Recommendations for future research: Pleural effusion 
Area of future research Question 
Non-expandable lung Are there any TUS techniques which might 
help to predict the development of non-
expandable lung? 
Improved diagnostics Can the use of newer technology or contrast 
material improve the diagnostic utility of 
TUS in characterizing effusions? 
Point-of-care Can point-of-care TUS for the detection of 
pleural effusions become standard practice 
for non-pulmonologists or radiologists? 
 
Conclusions 
The immediate and accurate identification of fluid prior to intervention remains the primary purpose of 
most TUS. Ongoing developments in technology, leading to even greater portability and higher 
resolution, will likely improve our ability to identify and characterise effusions, especially at an early 
stage, as may the use of fluid contrast agents, which remains relatively rare. 
4. Pneumothorax 
Overview of the evidence and current practice 
Pneumothorax has traditionally been identified on erect CXR. However, there has been increasing 
interest in the use of TUS in the identification of pneumothorax, particularly in the context of trauma 
and critical care [12]. The difficulty with TUS in pneumothorax is due to the high impedance of the 
tissue/air interface causing most of the US waves to be reflected. Therefore, both air in the lung and air 
in the pleural space create a bright line at the pleural surface. However, there are three specific features 
of TUS described in pneumothorax: a lack of “lung sliding”, the absence of “B-lines”, and identification of 
a “lung point” [85-87]. 
Lung sliding is a ”sparkling” of the pleural line as the lung moves with respiration [88]. If lung sliding is 
identified, then pneumothorax can be excluded in that area. Conversely, the absence of lung sliding is 
not specific for pneumothorax. Lung sliding can also be assessed using M-mode [89]. Lung sliding distal 
to the pleural line creates a granular pattern distal to the pleural line, referred to as the “seashore sign”. 
The absence of lung sliding creates lines known as the “bar-code” or “stratosphere” sign (fig. 3). 
Importantly, loss of lung sliding can be caused by hyperinflation or bullous emphysema in COPD [90] and 
pleural adhesions. 
“B-lines” (otherwise known as ”comet-tails”) are vertical artefacts projecting distally from the pleural 
line due to imperfections at the lung surface (fig. 3) [91]. The presence of B-lines excludes 
pneumothorax, but their absence does not confirm it. 
The “Lung point” is an ultrasonographic sign which attempts to locate the junction between the 
pneumothorax and area with no air between the visceral and parietal pleural, i.e. where the visceral and 
parietal pleural part company [92]. With a stationary probe, the lung point refers to a pattern of 
repeated transitions between no lung sliding or B-lines (pneumothorax) into a demonstrable area of 
sliding (lung). It has been suggested that identification of the lung point is 100% specific for 
pneumothorax [92], and, by marking the lung point at multiple locations on the chest wall, this can be 
used to determine pneumothorax size [93]. However, a lung point is only seen in partial 
pneumothoraces and will be dependent on patient position. 
TUS for pneumothorax can be challenging in small loculated pneumothoraces, and impossible in the 
context of significant subcutaneous emphysema where air in the subcutaneous tissue reflects all US 
waves (fig. 1). 
Studies have been published on the utility of TUS in pneumothorax diagnosis for over 20 years. The 
majority of these have been prospective case series comparing imaging modalities in diagnosing 
pneumothorax in the context of trauma, iatrogenic (post-image guided biopsy) or in critical care, but no 
randomised controlled trials have assessed clinical effect or outcome. Currently, four meta-analyses 
have been published pooling data comparing the accuracy of TUS for pneumothorax compared to CXR 
[94-97]. Pooled sensitivity for TUS was 78–90% and pooled specificity was >98%. CXR performed poorly 
with a pooled sensitivity of 39–52%, but a similar specificity. However, these results must be taken in 
context; the vast majority of studies included mainly trauma patients lying in a supine position in the 
emergency department (ED), which will naturally reduce the sensitivity of the CXR comparator. 
There was significant heterogeneity among all four meta-analyses, with one metanalysis suggesting it 
was due to operator performance [94], but a number of other factors could contribute. Importantly, 
pneumothoraces in trauma patients missed on supine CXR could have been occult. The diagnosis of 
occult pneumothorax has not been shown to impact clinical outcome and may indeed lead to over 
treatment (e.g. pleural drainage may not be required). 
The identification of pneumothorax post-lung biopsy was specifically assessed in three studies: Chung et 
al. performed high resolution CT (HRCT) scans on 97 patients  after fluoroscopic-guided lung biopsy, 
identifying pneumothorax in 36% [98]. The authors conclude a sensitivity of 80% for TUS but did not 
discriminate the size of pneumothorax; thus, these studies are likely to be identifying a number of small, 
clinically insignificant pneumothoraces on CT (in keeping with the higher than usual pneumothorax 
rate). Reissig et al studied 53 patients post transbronchial biopsy during bronchoscopy, with TUS 
identifying pneumothorax in all four (7.5%) cases [99]. Sartori et al also concluded that the sensitivity for 
TUS was 100% by examining 285 patients post-TUS-guided lung biopsy [100]. In this series only eight 
(2.8%) patients had pneumothorax, all of whom were identified by TUS; although CT was only 
performed when there was a discrepancy between TUS and CXR.  
Another application of TUS could be in determining when pneumothoraces have resolved after chest 
tube drainage. One study suggested that TUS was superior to CXR [101], but was limited by being a 
single centre study with small patients numbers (n=44).  
Table 4. Recommendations for future research: Pneumothorax  
Area of future research Question 
Trauma patients Can early TUS detection of pneumothorax 
positively impact the patient’s outcome? 
Post-lung biopsy Can TUS be used to identify iatrogenic 
pneumothorax requiring drainage? 
Pneumothorax – resolution Is TUS more sensitive than CXR in showing 
resolution of pneumothorax after successful 
drainage? (i.e. can we reduce the need for 
CXR?) 
Pneumothorax – predicting recurrence Can a lack of lung sliding on TUS at early 
follow-up predict long term recurrence? 
 
Conclusions 
The utility of TUS in diagnosing pneumothorax has been reported in many prospective case series mostly 
in the context of trauma, iatrogenic (post-image guided biopsy) or in critical care. Four meta-analyses 
suggest TUS has a better sensitivity for pneumothorax compared to CXR but there are no randomised 
controlled trials assessing clinical effect or outcome, and the performance may be operator dependent. 
The development of well-designed clinical trials will help to guide practice in the future. 
5. Interstitial syndrome 
Overview of the evidence and current practice 
The interstitial syndrome (IS) describes a composite TUS finding that represents an increased density of 
the lung interstitium secondary to a diffuse underlying disease or condition [102, 103]. The space and 
tissues around the alveolar sacs compose the lung interstitium and includes the alveolar epithelium, 
pulmonary capillary endothelium, basement membrane, perivascular- and perilymphatic tissues. If one 
or more of these tissues are affected in both lungs, IS may be present.  
Presence and quantification of B-lines constitute the cornerstone finding when aiming to identify and 
confirm IS [104]. B-lines arise due to continuous reflection of the US beam between increased lung 
density areas and non-aerated areas near the pleural line [105, 106], and are defined as vertical 
reverberation artefacts originating from the pleural line in synchrony with lung sliding, extending 
uninterrupted to the edge of the screen without fading (fig. 3) [107]. Several TUS scanning approaches 
involving a different number of scanning zones to detect IS have been recommended [5, 16, 17, 27, 108-
112], but the majority are expansions of Volpicielli et al. defining IS when 3 B-lines in >2 anterior or 
lateral lung interstitial spaces are present in each hemithorax [107]. In many settings cardiogenic and 
non-cardiogenic pulmonary oedema are the most common causative IS conditions, but other conditions 
such as acute respiratory distress syndrome (ARDS) also causes IS to be present [113]. In these 
conditions, IS arises due to hydrostasis or capillary leak with protein accumulation in the interstitium 
leading to interstitial and alveolar oedema [114]. A meta-analysis of 1,827 patients found TUS to be 
more sensitive to detect IS in dyspnoeic patients with acute HF (AHF) than CXR (88% vs. 73%), but with 
comparable specificities (90%) [115]. In a prospective multicentre study including 1,005 patients 
attending ED with acute dyspnea, Pivetta et al. found that adding TUS to a standard diagnostic regime 
was superior to detect IS as part of AHF [116]. Two randomised clinical trials (RCT) support these 
findings: Laursen et al. compared usual clinical assessment and diagnostics with an approach using 
point-of-care US of the lung, heart and deep veins alongside usual clinical assessment and diagnostics.  A 
significantly higher proportion received a correct diagnosis (88.0% vs. 63.7%) and treatment (78.0% vs. 
56.7%) in the US group compared to the usual clinical assessment and diagnostics group [5]. Pivetta et 
al. demonstrated an approach using TUS had a higher diagnostic accuracy than an approach using CXR 
and NT-proBNP (AUC 0.95 vs. 0.87, p < 0.01) for the diagnosis of AHF [117]. In the context of an intensive 
care setting, Bataille et al. however found that the presence of IS was poor in discriminating between 
cardiogenic pulmonary oedema and pneumonia, unless supplementary echocardiography was 
performed [118]. Whether the results of the two RCT’s can be generalized to other settings with more 
highly selected patients and whether TUS in the case of presence of IS should be routinely combined 
with echocardiography or focused cardiac ultrasound require further investigation. 
In addition to IS, pleural oedema and the development of pleural fibrosis may occur in ARDS giving rise 
to pleural irregularity and decreased lung sliding [23, 119]. However, extrapolation of data regarding 
diagnostic accuracy of IS detected in AHF may not necessarily be applied to IS in ARDS [120]. This also 
applies to patients undergoing dialysis, although a clear association between interstitial oedema 
identified by IS and fluid overload has been shown [121, 122]. Hence, besides its relevance as a 
diagnostic add-on modality in these ‘wet B-line’ conditions, TUS shows operational applicability to 
monitor IS dynamics and guide treatment [123-126].  
In interstitial lung diseases (ILD), IS arises from ongoing inflammation or formation of fibrosis following 
collagen accumulation in the interstitium resulting in distorted lung architecture with compromised 
alveolar aeration [106]. ILD represents a heterogeneous disease category involving idiopathic and 
connective tissue disease (CTD) related subtypes [110, 127]. The applicability of TUS to detect IS based 
on the number of B-lines has primarily been assessed within CTD-ILDs secondary to scleroderma, 
rheumatoid arthritis, Sjogren’s- and antisynthethase syndrome [108, 109, 128, 129]. In several of these 
studies, an increased number of B-lines correlated with disease severity better than HRCT [110, 128]. 
Furthermore, the presence of pleural irregularity and increased distance between B-lines were 
associated with increasing fibrosis and reduced lung physiological parameters such as total lung capacity 
(TLC) and diffusion capacity of the lung for carbon monoxide (DLCO) (fig. 3)[110]. Similar findings are 
observed in idiopathic ILDs [11]. A recent review proposed that TUS identified IS can be used to 
determine the distribution of an usual interstitial pneumonia pattern when comparing to a HRCT [130]. 
Though some studies have observed high diagnostic accuracies of TUS-related IS in ILDs compared to 
HRCT [109], it is questionable whether these are representative due to small study cohorts, 
misclassification of disease, and disease behaviour [131, 132]. 
The use of TUS for assessment of patients with coronavirus disease 2019 (COVID-19) has been reported 
in some initial studies following the outbreak of the pandemic. The typical pattern being reported as 
being presence of B-lines, IS and lung consolidation [133-135]. The currently published literature is 
however still relatively scarce and further studies are urgently needed [40, 134].  
Table 5. Recommendations for future research: Interstitial syndrome 
Area of future research Question 
ILD patients - identification Can early TUS detection of IS in ILD suspected patients 
reduce latency in ILD diagnosis?  
IS monitoring and impact Can TUS be used to monitor treatment and/or disease 
development? 
Studies assessing clinical impact of TUS identified IS are 
warranted. 
IS detection validity In patients with IS, does the number of B-lines per LIS 
relate to underlying cause of disease and disease severity? 
IS causality prediction Can the combination of IS with visceral pleural pathology 
be used to distinguish between underlying pulmonary or 
extrapulmonary conditions? 





The presence of IS is a dynamic surrogate marker of a disease or condition affecting the lung 
interstitium. As the genesis of IS does not clearly permit the differentiation between ‘wet’ and 
‘connective’ B-lines, the role of TUS is as an integrated clinical add-on modality together with 
supplemental diagnostic work-up in order to determine an underlying diagnosis, It may also be used to 
monitor disease behaviour and treatment response. However, available knowledge on TUS’ validity to 
identify IS in selected disease categories is lacking. This warrants further prospective large-scale studies 
to determine diagnostic cut-off points for TUS-detected IS before clarifying its clinical use in controlled 
trials. 
6. Lung consolidation 
Overview of the evidence and current practice 
The sonographic pattern of lung consolidation has been defined as a subpleural echo-poor region 
or one with tissue-like echotexture [1]. Animal and human studies have demonstrated that 
consolidation as it appears at TUS is the result of an increase in density of lung tissue, eventually 
resulting in complete de-aeration [24, 136]. This is the sole condition in which the lung can be 
visualized as a solid organ. Since many conditions (e.g. pneumonia, malignancy, pulmonary 
embolism, atelectasis, contusion, aspiration) may result in complete de-aeration of the lung 
tissue, lung consolidation is in itself a non-specific finding. Lung consolidation should be 
differentiated from the presence of B-lines in which the density of the lung tissue is increased but 
the lung parenchyma remains at least partially aerated and therefore does not allow visualisation 
of the lung parenchyma. 
In order to visualise lung consolidation by the use of TUS, the de-aerated lung area needs to be in 
contact with the chest wall (with or without interposition of fluid) in a “lung zone” which can be 
assessed transthoracically. Nonetheless, the diagnostic accuracy of TUS for lung consolidation has been 
shown to be higher than CXR when CT is used as the reference standard [137]. Studies with more robust 
designs limiting potential biases are however still warranted [138].   
Studies assessing different aspects of using TUS for diagnosing pneumonia, especially community 
acquired pneumonia, have been published since the 1980’s, with a steady increase with the more 
widespread availability of point-of-care US [26, 139-147]. In a meta-analysis by Orso et al. with a 
combined sample size of 5,108 patients, the pooled diagnostic accuracy of TUS for diagnosing 
pneumonia in the ED was: sensitivity 92% (95% confidence interval (CI) 87-96%), specificity 94% (95%CI 
87-97%) (fig. 4) [148]. The use of TUS integrated with clinical assessment and other diagnostic modalities 
including CXR seems to increase the overall diagnostic accuracy, but little is known of the clinical impact 
of TUS for diagnosing pneumonia [5, 149, 150]. Based on a study by Jones at al it seems that TUS can 
safely replace the CXR as the initial imaging modality of pneumonia in children and thus reduce radiation 
exposure [151]. The study did however report frequent use of CXR in the TUS group. Despite studies 
favouring the use of TUS over CXR for diagnosing pneumonia in adults, the optimal combination of TUS 
and CXR from a diagnostic and safety perspective has not been established. Several confounding factors 
in the intensive care setting make TUS diagnosis of pneumonia more complex, reducing the diagnostic 
accuracy; in this setting, a constellation of TUS additional signs and preliminary microbiological findings 
conversely yields a high diagnostic accuracy [147]. 
Despite the fact that using TUS for the diagnosis of pulmonary embolism (PE) was described more than 
50 years ago, research in the area has primarily evolved within the last two decades, with several 
descriptive and diagnostic accuracy studies [15, 29, 152-166]. In a meta-analysis of TUS’ diagnostic 
accuracy for PE, Squizzato et al. reported a bivariate weighted mean sensitivity and specificity of 87.0% 
(95%CI 79.5-92.0%) and 81.8% (95%CI 71.0-89.3%), respectively [167]. Based on these findings, TUS 
seems superior to other forms of mono-organ US for diagnosing PE [168, 169]. Several studies have 
advocated a whole-body-ultrasonography approach combining assessment of the lungs, heart and deep 
veins in patients with suspected PE or respiratory symptoms. This multi-organ approach is superior to 
what has been described using a mono-organ approach, but randomized trials assessing potential 
clinical impact and safety aspects are yet to be published [5, 22, 27, 29, 165, 170]. 
Several studies describing the use of TUS for assessing various other specific causes of lung consolidation 
(e.g. atelectasis, tumors, contusion) have been published. The findings and utility of TUS for assessing 
these conditions may be highly clinically relevant (e.g. assessment of invasive growth) but most of the 
studies are of a descriptive nature or with relatively small sample sizes (fig. 4) [19, 44, 171-182].  
While most of the previous research has aimed to assess the use of TUS as a diagnostic tool, increasing 
attention is being directed at TUS’ abilities as a monitoring tool [183]. The basic principles on how TUS 
can be used in real-time to monitor a gradual change from normal pattern to interstitial syndrome, lung 
consolidation, and subsequent reversal of these findings have been well described using a whole lung 
lavage model [24]. Several TUS monitoring studies have reported promising and clinically relevant 
results, especially in the intensive care setting of Acute Respiratory Distress Syndrome (ARDS), 
ventilator-associated pneumonia, and weaning from mechanical ventilation.  However, there is still a 
lack of robust data on TUS oriented management in improving clinical outcomes [6, 112, 124, 141, 184-
190]. 
Table 6. Recommendations for future research: Lung consolidation 
Area of future research Question 
Inter- and intra-observer 
agreement 
What is the inter- and intra-observer agreement for 
diagnosing conditions causing lung consolidation in a 
population of unselected patients with various different 
lung diseases? 
Clinical impact Can the apparent good diagnostic accuracy of TUS also 
lead to improvement in clinically relevant outcomes? 
Implementation If TUS is to be implemented in clinical practice, how should 
it then be ideally used alongside other diagnostic 
modalities? 
Monitoring  Can the use of TUS for monitoring consolidation lead to 
improvement in clinically relevant outcomes? 
 
Conclusions 
Based on currently published studies, TUS has a role as a bedside tool for assessing patients with 
possible or known lung consolidation, and potentially as a monitoring tool. Future research should focus 
on TUS’ effect on clinically relevant outcomes and how TUS is ideally used alongside other diagnostic 
modalities. 
7. Diaphragm  
Overview of the evidence and current practice 
Diaphragm mobility and thickness have been correlated with respiratory muscle strength and lung 
function in healthy subjects [191, 192]. In 27 patients with hemidiaphragm paralysis, diaphragm mobility 
during quiet breathing, thickness at functional residual capacity (FRC) and TLC, and diaphragmatic 
thickening fraction (TF = diaphragmatic thickness variation during respiration) were decreased on the 
side of the hemidiaphragm paralysis when compared to the non-paralysed hemidiaphragm [193]. TUS 
was more sensitive than fluoroscopy to detect hemidiaphragm movement abnormalities, with 4/30 
technical failures for fluoroscopy and no failures for TUS [194]. Even though the diaphragm has 
traditionally been assessed using conventional B- or M-mode, a few studies have indicated that more 
advanced techniques (e.g. Area method, speckle tracking) might prove more accurate and feasible [195-
197].   
TUS assessment of the diaphragm in the intensive care unit 
Spontaneous breathing trials (SBT) are used to predict weaning outcomes in patients on mechanical 
ventilation (MV); however, 13-26% of those extubated after successful SBT need rescue non-invasive 
ventilation or are re-intubated within 48-72 hours [198, 199]. Ventilation-induced diaphragm 
dysfunction is often observed in patients who are difficult to wean off MV, and can be assessed by TUS 
by measuring diaphragm thickness at end expiration, or more dynamic evaluation of TF or diaphragm 
excursion (DE) at the zone of apposition of the pleural and peritoneal membranes. Data on TUS 
parameters and weaning is varied; in a systematic review including 19 studies and 1,071 patients on 
invasive MV for at least 24 hours, the area under the operating curve for TF was 0.87, with a pooled 
diagnostic odd’s ratio (DOR) 21 (95% CI 11-40), and pooled sensitivity for DE was 75%, DOR 10 (95% CI 4-
24)[200]. Another meta-analysis (13 studies and 742 patients) reported pooled sensitivity of 90%, 
specificity 80%, and DOR 32.5 (95% CI 18.6 - 56.8) for TF, and 80%, 70%, 10.6 (95% CI 4.2 - 27.1) 
respectively for DE [201]. Low TF was a good predictor of weaning outcome with consistency across 
studies, and higher DOR suggests that TF has better diagnostic accuracy than DE. Both TF and DE are 
reproducible [195, 200, 202-206]. In a large multicentre RCT by Vivier et al, diaphragmatic dysfunction 
identified by TUS was however not associated with an increased risk of extubation failure [207]. Hence, 
further studies are needed to establish the exact role of TUS assessment of the diaphragm in 
mechanically ventilated patients.  
Pleural effusion  
The mechanism of breathlessness in pleural effusion is not fully understood. Pleural effusion adversely 
affects the diaphragm’s ability to generate negative pressure, and this is postulated to be a cause of 
breathlessness. In 14 MV patients on pressure support ventilation with a pleural effusion, respiratory 
rate decreased, tidal volume increased, and diaphragm displacement and thickening increased after 
pleural fluid aspiration, with correlation between volume of effusion drained and increase in tidal 
diaphragm thickening [208]. When TUS was performed before and after thoracoscopy (14/19 MPE), 
larger effusion volumes were associated with impaired diaphragm movement compared to effusions 
with normal diaphragm movement [209]. After pleural aspiration, patients with paradoxical movement 
of the hemidiaphragm (n=21) had a small but significant improvement in forced expiratory volume in 1 
second (FEV1), forced vital capacity (FVC), PaO2, A-a oxygen gradient, and dyspnoea, whereas those 
without paradoxical movement of the diaphragm (n=41) did not [210]. In a larger study (n=145) of 
patients with symptomatic pleural effusions, Muruganandan et al. showed TUS demonstrating abnormal 
hemi-diaphragm shape and movement prior to thoracentesis were independently associated with relief 
of breathlessness post-drainage [211]. These results suggest diaphragm flattening or abnormal 
movement are strong indications for aspiration to restore normal diaphragm position and shape, and 
TUS can aid in this assessment. 
Other 
Diaphragm mobility has been shown to be decreased in COPD patients compared to healthy subjects. DE 
correlates with lung function [212, 213], and TF in acute exacerbations of COPD complicated by 
respiratory acidosis correlated with non-invasive ventilation (NIV) failure, longer intensive care unit stay, 
prolonged MV, need for tracheotomy and mortality [214, 215]. TF predicted nocturnal hypoxaemia in 
COPD with mild or no daytime hypoxaemia [216].  
A review of respiratory muscle imaging modalities in neuromuscular disorders (NMD) identified 9 
studies (n=292 patients) that used US [217]. Diaphragm thickness was significantly lower in patients with 
NMD than in healthy controls [218, 219], and in amyotrophic lateral sclerosis was positively correlated 
with vital capacity, and negatively correlated with PaCO2, with good interobserver reliability [220].  
Table 7. Recommendations for future research: Diaphragm 
Area of future research Question 
Novel imaging in transdiaphragmatic 
pressure assessment 
Does Speckle tracking measurement 
correlate with transdiaphragmatic 
pressure? 
Novel imaging in diaphragm function 
assessment 
Is an assessment of the entire 
hemidiaphragm dome movement using 
the Area method better than a single 
point measurement using M-mode? 
Ventilation Can TUS be used to assess patient-ventilator 
asynchrony? 
Risk of extubation failure Does TUS have a role for predicting risk of 
extubation failure?  
 
Conclusions 
TUS assessment of the diaphragm has been assessed in various clinical settings. Studies are however 
mostly small observational studies, the findings of which are not yet well validated, and it is as yet 
unclear whether TUS findings can be translated to clinically meaningful outcomes. In addition, most 
studies are either done in healthy volunteers or in small highly selected populations.  More data from 
larger studies is necessary.  
8. US guided procedures  
Overview of the evidence and current practice 
The increased use of TUS has transformed the scope of procedures the interventional pulmonologist is 
able to offer. Studies have consistently demonstrated that TUS is safer than clinical examination in direct 
comparison [221], and reduces risk and cost of iatrogenic complications [222-224]. The current position 
of most international guidelines is that all pleural procedures (for fluid) should be performed under TUS 
guidance [3]. Clinical research has highlighted the diagnostic and therapeutic value of pleural 
interventions in improving key outcomes [225, 226], further challenging the physician to extend their 
procedural boundaries with the aid of TUS, to meet an increasing patient demand and improve 
accessibility.  
As well as pre-procedure TUS guiding optimal pleural puncture site, real-time US imaging can facilitate 
thoracentesis of small effusions, where most experts suggest at least 1cm depth is required to be safe 
[42]. In the setting of loculated effusions, the introducer needle of the aspiration catheter can be guided 
towards the largest collection of fluid, whilst being used to traverse and break up septations along its 
course [227]. Post-procedure US can rule out pneumothorax with up to 100% negative predictive value 
[85]. The use of colour Doppler can screen for the intercostal artery at the site of intervention pre-
procedure as well as confirm absence of post-procedure haemorrhage [228, 229]. 
TUS provides similar procedural benefits in chest tube insertion. TUS is not currently recommended to 
guide drainage of pneumothorax. Currently used techniques for chest tube insertion are ‘Seldinger’ (or 
guide-wire), blunt dissection and the trocar method. Most of the data suggests that 12-French (F) drain 
is an appropriate size for the majority of pleural drainage indications, providing a balance of safety, 
effectiveness and patient comfort [230, 231]. A retrospective analysis of the largest prospective RCT of 
pleural infection to date (MIST-1; n=405) [232], showed that there was no significant difference in 
frequency of death or surgery in patients managed with small bore (<15F) chest tubes [231]. In addition, 
their suitability for intrapleural fibrinolysis makes them an appropriate treatment choice [233]. The 
optimal size of chest tube for pleurodesis is still an area of controversy with some studies suggesting 
small bore (<14F) drains may be less effective [234, 235]. Based on these studies the pulmonologist will 
be able to handle the majority of indications for chest tube insertions by the use of TUS guided insertion 
of small bore chest tubes. 
Indwelling pleural catheters (IPCs) have had a huge impact on the management of recurrent malignant 
pleural effusions [236], with ongoing studies looking to delineate their place in benign effusions. While 
TUS plays an established role in guiding initial insertion, it may potentially guide the selection of patients 
who may be more suitable for IPCs rather than drainage and pleurodesis. The identification of non-
expandable lung has been traditionally achieved through drainage of pleural fluid followed by a CXR 
demonstrating pneumothorax ex vacuo or using pleural manometry [237]. Recently published data 
suggests that speckle tracking imaging analysis and M-mode can identify entrapped lung prior to 
effusion drainage, allowing upfront choice of definitive management option [84]. 
Local anaesthetic thoracoscopy (LAT) has now become the gold standard investigation of an 
undiagnosed unilateral pleural effusion and/or suspected malignancy [238], with an increasing number 
of centres having routine access [239]. TUS is a vital accessory to LAT, allowing the operator to assess 
volume of fluid, presence/absence of lung sliding, degree of septation as well as characterising the 
nature of pleural and diaphragmatic thickening and nodularity. The operator is then able to target entry 
point for maximal success or conversion to an alternative intervention in the same visit, e.g. if effusion 
volume deemed to be inadequate. In this circumstance, TUS can facilitate artificial pneumothorax-
induction in suitable patients, using real-time introduction of a Boutin needle or blunt dissection [240, 
241]. Another option in this setting, and increasingly conducted by physicians in recent years, is TUS-
guided closed pleural biopsy (fig. 4). This technique is particularly advantageous in the elderly or frail 
patient, as a less invasive alternative to LAT. In the hands of an experienced operator, TUS-guided 
pleural biopsy outcomes are comparable to those conducted by specialised colleagues in radiology [4]. 
To date, there is no robust evidence to determine whether newer core-cutting needles are superior to 
traditional reverse bevel (e.g. Abrams) needles. 
TUS-guided lung biopsy conducted by pulmonologists is not only safe and feasible with comparable 
yields [242, 243], but may also be advantageous over radiologist-led CT guided biopsy due to shorter 
procedure times, quicker access, and limited risk of complications [244-246] (fig. 4). The supplementary 
use of more advanced ultrasound modalities such as contrast-enhanced US and elastography could have 
a role for selecting patients with a high risk of malignancy for subsequent biopsy and to guide the choice 
of biopsy site thereby increasing the diagnostic yield of the biopsy procedure [247-251]. 
Pulmonologists performing focused US of structures related to the chest (e.g. neck) and subsequent US 
guided biopsy has been described and potentially provides a rapid, less invasive method for obtaining a 
diagnosis and staging patients with suspected thoracic malignancy [252-255].  A potential role has also 
been described in other diseases with extrapulmonary involvement (e.g. sarcoidosis, tuberculosis) [256-
258].  
Table 8. Recommendations for future research: US guided procedures 
Area of future research Question 
Contrast-enhanced US-guided biopsy Can contrast-enhanced US improve 
diagnostic yield from TUS-guided biopsy 
through differentiating benign and 
malignant pleural disease?  
Tissue elastography-guided biopsy Can TUS elastography reliably allow non-
invasive differentiation between benign 
(soft) and malignant (hard) tissue 
(pleura/lung) to guide TUS biopsy? 
US-guided intervention based on US-
guided assessment of breathlessness 
Therapeutic pleural aspiration based on US 
guided assessment of breathlessness to 
differentiate from non-pleural effusion 
related breathlessness 
Conclusions 
TUS is portable, cost-effective and adds diagnostic and therapeutic value in guiding pleural 
interventions. As an increasing number of practitioners continue to extend the scope and complexity of 
procedures they undertake, it is important to recognise limitations, both of operator and environment, 
and remain safe and evidence-based at all times.  
9. Training 
Overview of the evidence and current practice 
TUS has no direct complications or risks, but important decisions are made based on TUS and competent 
operators are essential to achieve a high diagnostic accuracy [259-261]. Structured and evidence-based 
training and assessment of new operators are necessary to ensure competence [2, 262]. A systematic 
review in training methods and assessment in TUS was published in 2018 with 16 included articles [262]. 
Since then, 12 articles were published and eligible for inclusion in this statement. 
Procedural competence in TUS is often taught at the bed-side, during rounds by an experienced 
colleague, or at courses with a fixed time frame [3, 263-266]. Unfortunately, the clinical setting can be 
an un-systematic and stressful environment where learning is dependent on the simultaneous 
availability of suitable patients and skilled supervisors. Several TUS courses exist, but the fixed time 
frame makes it impossible to guarantee all trainees reach competence in scanning a range of different 
pathologies. Additionally, implementation and integration of the technical procedure is just as 
important as learning the procedure itself, meaning that feedback and clinical discussions with other US 
operators are important. 
Simulation or phantom-based training provides a stress-free and standardized learning environment 
where individual trainees can continue practicing their technical skills and hand-eye coordination until 
they have acquired necessary competencies [267, 268]. Trainees’ hands-on training time is maximized 
and the need for expert supervision is reduced which can make simulation-based training more effective 
and economically advantageous [269]. 
Hands-on training, whether on simulators or by scanning simulated patients or healthy volunteers, must 
be based on solid theoretical knowledge to improve the efficacy of training and must be followed by 
supervised refinement of skills in the clinic until independent competency is acquired. A fixed timeframe 
or an arbitrary number of performed/supervised procedures do not equal obtained competence; all 
trainees learn at different learning paces [270]. 
The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), and Royal 
College of Radiologists have made recommendations about what topics to include in a theoretical 
curriculum (table 9) [265, 266]. Several studies assess new operators’ theoretical knowledge by using 
theoretical tests covering the same topics, or nearly the same topics [263, 271-273]. Many different 
learning methods have been used; e.g. classroom-based lectures, group sessions, web-based sessions, 
or individual homework with books or papers [273-276]. All studies showed increased knowledge 
regardless of the learning method used, but only one study presented validity evidence for the 
theoretical test that was used [277]. 
Table 9. Comparing the recommendations on theoretical knowledge needed for completion of level 1 
practitioner in TUS by different organisations. 
The Royal College of Radiologists UK   EFSUMB       
Physics and technology, US technique and 
administration 
 
Physics, US techniques and administration 
Sectional and ultrasonic anatomy   Anatomy   
  Right and left hemidiaphragms   Right and left hemidiaphragms   
  Heart   Heart   
  Liver and spleen   Liver and spleen   
  Rib and intercostal space   Rib and intercostal space   
    Superior and anterior mediastinum   
    Chest wall   
    
Supraclavicular region 
   
Pathology in relation to US   Pathology in relation to US   
  Pleural effusion   Pleural effusion   
  Pleural thickening   Pleural thickening   
  Consolidated lung   Consolidated lung   
  Paralysed hemidiaphragm    Paralysed hemidiaphragm    
  Pericardial effusion   Pericardial effusion   
    Pneumothorax   
    Chest wall abnormalities   
 
Practical hands-on training was included in a majority of studies [263, 264, 272, 274-276, 278-282]. 
Several hands-on training modalities are represented and probably useful, including animal models, 
virtual reality simulators, phantoms, and humans (healthy volunteers or patients with pulmonary 
disease/symptoms). However, the study designs and methods were heterogeneous, outcomes measures 
without evidence of validity were used, and results were difficult to compare. Two studies have 
presented simulator models with validity evidence for practical assessment [283, 284], several tools for 
assessment in a clinical setting were identified [285-287], and a guide for a minimum training standard 
with both theoretical and practical training by experienced TUS operators is proposed [288].  
Gaps in knowledge and/or evidence in training and assessing TUS 
Just as physicians are expected to treat and practise according to best medical evidence, educators 
should use the best available evidence to guide their education in the best possible direction [289]. 
Geographical, financial, and administrative aspects can affect the possibilities to educate on the highest 
possible level. No studies have assessed the effect of different hands-on training modalities, the 
educational intervention on an institutional level, or used patient outcomes as a primary endpoint. 
These studies are needed to propose recommendations on a European level. 
Table 10. Recommendations for future research: Training 
Area of future research Question 
Comparison of clinical assessment tools What advantages and disadvantages do 
the current assessment tools have and 
which is more effective in an educational 
setting? 
Patient related outcome of an 
educational intervention 
Can an educational intervention increase 
patient outcome? 
Effect of an educational intervention on 
clinical decision making 
Can an educational intervention in TUS 
improve the integration of TUS with the 
clinical decision-making process?  
Patient communication How can patient communication during 




A TUS curriculum should be well planned and evidence-based similar to the requirement for clinical 
practice. The ERS have launched such a training program in 2020. Heterogeneous case load, scarcity of 
expert supervision, and different learning paces are major challenges to education in a clinical setting. 
Suitable, objective assessments with solid evidence of validity are necessary to ensure competence at 
each step before independent practice moving towards competency-based training and Entrusted 
Professional Activities.  
10. Patient perspectives 
Overview of the evidence 
The literature search could not identify any quantitative or qualitative studies specifically addressing this 
topic. Four articles were included for review addressing patient discomfort and satisfaction with US in 
emergency department settings and included but were not limited to TUS [290-293]. Key themes 
identified were high patient satisfaction, low levels of discomfort with bedside US, and patient-provider 
interactions. 
Patient satisfaction 
Bedside US in the emergency department was found to increase patient satisfaction in two studies [290, 
291]. Heating the US gel did not significantly increase patient satisfaction, overall satisfaction with the 
emergency department visit, or patient perceptions of physician professionalism [293]. Patient feedback 
indicated that bedside scanning is also welcome outside the emergency setting, particularly if the 
patient is having trouble breathing as it avoids the additional strain of visiting multiple hospital 
departments. Patients may take comfort from understanding the lower risks of ultrasound when 
compared to other imaging techniques, such as CT. Exposure to radiation is of concern to patients, 
particularly if multiple scans are required over time. 
Discomfort 
The majority of patients do not experience discomfort during point-of-care US of the heart, lungs and 
deep veins [292]. An increased level of discomfort was most often due to an underlying condition (e.g. 
rib fracture) or the result of an intervention (e.g. resuscitation) causing localised pain. Most patients, 
including those who experience some discomfort, would be willing to accept US assessment in future. 
Professionals should inform patients with an underlying condition that they may experience discomfort 
before performing US. 
Patient-provider interactions 
Bedside US may improve communication between patients and professionals by offering the chance to 
explain examination results and provide a clearer understanding of the patient’s diagnosis [290, 291]. 
Professionals’ communication skills play a crucial role in patient experience of imaging. Professionals 
should be mindful of the language they use and avoid jargon when discussing the procedure and results. 
Table 11. Recommendations for future research: Patient perspectives 
Area of future research Question 
Patient experiences What are the patient experiences of TUS 
in a variety of settings (e.g. emergency 
department, intensive care unit, 
outpatient clinic) 
Patient preferences  What are the patient experiences and 
preferences of TUS alongside other 
diagnostic and imaging tools (e.g. 
sequencing, overall burden of diagnostic 
testing) 
Patients with lung conditions What are the experiences and 
preferences of TUS for patients with 
existing lung conditions? 
Patient information What are patients’ information needs 
before, during and after TUS? 
Communication techniques What are the most effective 
communication techniques between 




TUS is acceptable to most patients in emergency department settings. Further qualitative studies are 
needed to fully understand patient experiences and preferences of TUS. 
Overall conclusions  
Continued clinical use and research has established TUS as a key-tool and skill for the modern 
pulmonologist. The increased availability of US equipment has helped facilitate the implementation and 
use of TUS across Europe and world-wide. Since US examinations historically have been provided by 
other specialties, many of the national and international respiratory societies have no tradition or 
recommendations for the use of TUS. The clinical use of TUS by pulmonologists is therefore in many 
ways far ahead of the guidelines and recommendations. A potential advantage of TUS is the relatively 
short pathway from research to clinical implementation, with the major disadvantage however being a 
general lack of consensus, and research results being implemented without sufficient scientific evidence 
to support such implementation. In order to achieve a further “professionalisation” of pulmonologists 
performing TUS, societal guidelines and recommendations from national and international respiratory 
societies are called for. The aim of this task force statement was to provide a state-of-the art summary 
guide for the pulmonologist of the current use of TUS and to identify key future research areas. This first 
official ERS statement on TUS is an important step to further advance professionalisation of TUS at an 
international level, which will in turn benefit the many patients being assessed by physicians in this way 
on a daily basis. 
Acknowledgements 
We thank David Rigau Comas for providing valuable methodological assistance and support during the 
making of the statement. 
  
References 
1. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, 
Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, 
Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, 
Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T, International Liaison Committee on Lung 
Ultrasound for International Consensus Conference on Lung U. International evidence-
based recommendations for point-of-care lung ultrasound. Intensive care medicine 2012: 
38(4): 577-591. 
2. Laursen CB RN, Volpicelli G. ERS Monograph - Thoracic Ultrasound. In: Society ER, 
ed., 2018. 
3. Havelock T, Teoh R, Laws D, Gleeson F, Group BTSPDG. Pleural procedures and 
thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010: 
65 Suppl 2: ii61-76. 
4. Hallifax RJ, Corcoran JP, Ahmed A, Nagendran M, Rostom H, Hassan N, Maruthappu 
M, Psallidas I, Manuel A, Gleeson FV, Rahman NM. Physician-based ultrasound-guided 
biopsy for diagnosing pleural disease. Chest 2014: 146(4): 1001-1006. 
5. Laursen CB, Sloth E, Lassen AT, Christensen R, Lambrechtsen J, Madsen PH, 
Henriksen DP, Davidsen JR, Rasmussen F. Point-of-care ultrasonography in patients 
admitted with respiratory symptoms: a single-blind, randomised controlled trial. The 
Lancet Respiratory medicine 2014: 2(8): 638-646. 
6. Bouhemad B, Liu ZH, Arbelot C, Zhang M, Ferarri F, Le-Guen M, Girard M, Lu Q, 
Rouby JJ. Ultrasound assessment of antibiotic-induced pulmonary reaeration in ventilator-
associated pneumonia. Critical care medicine 2010: 38(1): 84-92. 
7. Mathis G, Sparchez Z, Volpicelli G. EFSUMB - European Course Book. Chest 
Sonography.  2010  [cited; Available from: http://www.efsumb.org/intro/home.asp 
8. Via G, Hussain A, Wells M, Reardon R, ElBarbary M, Noble VE, Tsung JW, Neskovic 
AN, Price S, Oren-Grinberg A, Liteplo A, Cordioli R, Naqvi N, Rola P, Poelaert J, Gulic TG, 
Sloth E, Labovitz A, Kimura B, Breitkreutz R, Masani N, Bowra J, Talmor D, Guarracino F, 
Goudie A, Xiaoting W, Chawla R, Galderisi M, Blaivas M, Petrovic T, Storti E, Neri L, Melniker 
L. International evidence-based recommendations for focused cardiac ultrasound. Journal 
of the American Society of Echocardiography : official publication of the American Society of 
Echocardiography 2014: 27(7): 683 e681-683 e633. 
9. Targhetta R. Ultrasonographic approach to diagnosing hydropneumothorax. CHEST 
Journal 1992: 101(4): 931. 
10. Targhetta R, Chavagneux R, Bourgeois JM, Dauzat M, Balmes P, Pourcelot L. 
Sonographic approach to diagnosing pulmonary consolidation. Journal of ultrasound in 
medicine : official journal of the American Institute of Ultrasound in Medicine 1992: 11(12): 
667-672. 
11. Reissig A, Kroegel C. Transthoracic sonography of diffuse parenchymal lung disease: 
the role of comet tail artifacts. Journal of ultrasound in medicine : official journal of the 
American Institute of Ultrasound in Medicine 2003: 22(2): 173-180. 
12. Kirkpatrick AW, Sirois M, Laupland KB, Liu D, Rowan K, Ball CG, Hameed SM, Brown 
R, Simons R, Dulchavsky SA, Hamiilton DR, Nicolaou S. Hand-Held Thoracic Sonography for 
Detecting Post-Traumatic Pneumothoraces: The Extended Focused Assessment With 
Sonography For Trauma (EFAST). The Journal of Trauma: Injury, Infection, and Critical Care 
2004: 57(2): 288-295. 
13. Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, Picano E. Usefulness 
of ultrasound lung comets as a nonradiologic sign of extravascular lung water. The 
American journal of cardiology 2004: 93(10): 1265-1270. 
14. Blaivas M, Lyon M, Duggal S. A prospective comparison of supine chest radiography 
and bedside ultrasound for the diagnosis of traumatic pneumothorax. Academic emergency 
medicine : official journal of the Society for Academic Emergency Medicine 2005: 12(9): 844-
849. 
15. Mathis G, Blank W, Reissig A, Lechleitner P, Reuss J, Schuler A, Beckh S. Thoracic 
ultrasound for diagnosing pulmonary embolism: a prospective multicenter study of 352 
patients. Chest 2005: 128(3): 1531-1538. 
16. Agricola E, Bove T, Oppizzi M, Marino G, Zangrillo A, Margonato A, Picano E. 
"Ultrasound comet-tail images": a marker of pulmonary edema: a comparative study with 
wedge pressure and extravascular lung water. Chest 2005: 127(5): 1690-1695. 
17. Volpicelli G, Mussa A, Garofalo G, Cardinale L, Casoli G, Perotto F, Fava C, Frascisco 
M. Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. The 
American journal of emergency medicine 2006: 24(6): 689-696. 
18. Bedetti G, Gargani L, Corbisiero A, Frassi F, Poggianti E, Mottola G. Evaluation of 
ultrasound lung comets by hand-held echocardiography. Cardiovascular ultrasound 2006: 
4: 34. 
19. Soldati G, Testa A, Silva FR, Carbone L, Portale G, Silveri NG. Chest ultrasonography 
in lung contusion. Chest 2006: 130(2): 533-538. 
20. Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G. Ultrasound lung 
comets: a clinically useful sign of extravascular lung water. Journal of the American Society 
of Echocardiography : official publication of the American Society of Echocardiography 2006: 
19(3): 356-363. 
21. Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Thomas SH, Harris NS. Chest 
ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema. Chest 
2007: 131(4): 1013-1018. 
22. Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute 
respiratory failure: the BLUE protocol. Chest 2008: 134(1): 117-125. 
23. Copetti R, Soldati G, Copetti P. Chest sonography: a useful tool to differentiate acute 
cardiogenic pulmonary edema from acute respiratory distress syndrome. Cardiovascular 
ultrasound 2008: 6: 16. 
24. Via G, Lichtenstein D, Mojoli F, Rodi G, Neri L, Storti E, Klersy C, Iotti G, Braschi A. 
Whole lung lavage: a unique model for ultrasound assessment of lung aeration changes. 
Intensive care medicine 2010: 36(6): 999-1007. 
25. Prosen G, Klemen P, Strnad M, Grmec S. Combination of lung ultrasound (a comet-
tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure 
from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in 
prehospital emergency setting. Critical care 2011: 15(2): R114. 
26. Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P, Aliberti S, Neumann 
R, Kroegel C, Hoyer H. Lung ultrasound in the diagnosis and follow-up of community-
acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012: 
142(4): 965-972. 
27. Laursen CB, Sloth E, Lambrechtsen J, Lassen AT, Madsen PH, Henriksen DP, 
Davidsen JR, Rasmussen F. Focused sonography of the heart, lungs, and deep veins 
identifies missed life-threatening conditions in admitted patients with acute respiratory 
symptoms. Chest 2013: 144(6): 1868-1875. 
28. Laursen CB, Hanselmann A, Posth S, Mikkelsen S, Videbaek L, Berg H. Prehospital 
lung ultrasound for the diagnosis of cardiogenic pulmonary oedema: a pilot study. 
Scandinavian journal of trauma, resuscitation and emergency medicine 2016: 24(1): 96. 
29. Nazerian P, Volpicelli G, Gigli C, Becattini C, Sferrazza Papa GF, Grifoni S, Vanni S, 
Ultrasound Wells study g. Diagnostic performance of Wells score combined with point-of-
care lung and venous ultrasound in suspected pulmonary embolism. Academic emergency 
medicine : official journal of the Society for Academic Emergency Medicine 2016. 
30. Dalen H, Gundersen GH, Skjetne K, Haug HH, Kleinau JO, Norekval TM, Graven T. 
Feasibility and reliability of pocket-size ultrasound examinations of the pleural cavities and 
vena cava inferior performed by nurses in an outpatient heart failure clinic. Eur J 
Cardiovasc Nurs 2015: 14(4): 286-293. 
31. Graven T, Wahba A, Hammer AM, Sagen O, Olsen O, Skjetne K, Kleinau JO, Dalen H. 
Focused ultrasound of the pleural cavities and the pericardium by nurses after cardiac 
surgery. Scandinavian cardiovascular journal : SCJ 2015: 49(1): 56-63. 
32. Volpicelli G, Cardinale L, Mussa A, Valeria C. Diagnosis of cardiogenic pulmonary 
edema by sonography limited to the anterior lung. Chest 2009: 135(3): 883; author reply 
883-884. 
33. Frasure SE, Matilsky DK, Siadecki SD, Platz E, Saul T, Lewiss RE. Impact of patient 
positioning on lung ultrasound findings in acute heart failure. Eur Heart J Acute Cardiovasc 
Care 2015: 4(4): 326-332. 
34. Scali MC, Zagatina A, Simova I, Zhuravskaya N, Ciampi Q, Paterni M, Marzilli M, 
Carpeggiani C, Picano E. B-lines with Lung Ultrasound: The Optimal Scan Technique at Rest 
and During Stress. Ultrasound Med Biol 2017: 43(11): 2558-2566. 
35. Anderson KL, Fields JM, Panebianco NL, Jenq KY, Marin J, Dean AJ. Inter-rater 
reliability of quantifying pleural B-lines using multiple counting methods. Journal of 
ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 
2013: 32(1): 115-120. 
36. Ketelaars R, Gulpinar E, Roes T, Kuut M, van Geffen GJ. Which ultrasound transducer 
type is best for diagnosing pneumothorax? Crit Ultrasound J 2018: 10(1): 27. 
37. Bobbia X, Chabannon M, Chevallier T, de La Coussaye JE, Lefrant JY, Pujol S, Claret 
PG, Zieleskiewicz L, Roger C, Muller L. Assessment of five different probes for lung 
ultrasound in critically ill patients: A pilot study. Am J Emerg Med 2018: 36(7): 1265-1269. 
38. Helland G, Gaspari R, Licciardo S, Sanseverino A, Torres U, Emhoff T, Blehar D. 
Comparison of Four Views to Single-view Ultrasound Protocols to Identify Clinically 
Significant Pneumothorax. Acad Emerg Med 2016: 23(10): 1170-1175. 
39. Tasci O, Hatipoglu ON, Cagli B, Ermis V. Sonography of the chest using linear-array 
versus sector transducers: Correlation with auscultation, chest radiography, and computed 
tomography. J Clin Ultrasound 2016: 44(6): 383-389. 
40. World Federation for Ultrasound in M, Biology Safety C, Abramowicz JS, Basseal JM. 
World Federation for Ultrasound in Medicine and Biology Position Statement: How to 
Perform a Safe Ultrasound Examination and Clean Equipment in the Context of COVID-19. 
Ultrasound in medicine & biology 2020: 46(7): 1821-1826. 
41. Carter BW, Benveniste MF, Betancourt SL, de Groot PM, Lichtenberger JP, 3rd, Amini 
B, Abbott GF. Imaging Evaluation of Malignant Chest Wall Neoplasms. Radiographics 2016: 
36(5): 1285-1306. 
42. Marchetti G, Arondi S, Baglivo F, Lonni S, Quadri F, Valsecchi A, Venturoli N, Ceruti P. 
New insights in the use of pleural ultrasonography for diagnosis and treatment of pleural 
disease. Clin Respir J 2018: 12(6): 1993-2005. 
43. Mullan CP, Madan R, Trotman-Dickenson B, Qian X, Jacobson FL, Hunsaker A. 
Radiology of chest wall masses. AJR American journal of roentgenology 2011: 197(3): 
W460-470. 
44. Bandi V, Lunn W, Ernst A, Eberhardt R, Hoffmann H, Herth FJ. Ultrasound vs. CT in 
detecting chest wall invasion by tumor: a prospective study. Chest 2008: 133(4): 881-886. 
45. Sripathi S, Mahajan A. Comparative study evaluating the role of color Doppler 
sonography and computed tomography in predicting chest wall invasion by lung tumors. 
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in 
Medicine 2013: 32(9): 1539-1546. 
46. Battle C, Hayward S, Eggert S, Evans PA. Comparison of the use of lung ultrasound 
and chest radiography in the diagnosis of rib fractures: a systematic review. Emergency 
medicine journal : EMJ 2019: 36(3): 185-190. 
47. Tobin C, Lee YCG, Gleeson F, Rahman N, Feller-Kopman D. Pleural Ultrasound for 
Clinicians: A Text and E-book. CRC Press, 2014. 
48. Wallbridge P, Parry SM, Das S, Law C, Hammerschlag G, Irving L, Hew M, Steinfort D. 
Parasternal intercostal muscle ultrasound in chronic obstructive pulmonary disease 
correlates with spirometric severity. Sci Rep 2018: 8(1): 15274. 
49. Nakanishi N, Oto J, Ueno Y, Nakataki E, Itagaki T, Nishimura M. Change in diaphragm 
and intercostal muscle thickness in mechanically ventilated patients: a prospective 
observational ultrasonography study. J Intensive Care 2019: 7: 56. 
50. Umbrello M, Formenti P, Lusardi AC, Guanziroli M, Caccioppola A, Coppola S, 
Chiumello D. Oesophageal pressure and respiratory muscle ultrasonographic 
measurements indicate inspiratory effort during pressure support ventilation. British 
journal of anaesthesia 2020: 125(1): e148-e157. 
51. Dres M, Dube BP, Goligher E, Vorona S, Demiri S, Morawiec E, Mayaux J, Brochard L, 
Similowski T, Demoule A. Usefulness of Parasternal Intercostal Muscle Ultrasound during 
Weaning from Mechanical Ventilation. Anesthesiology 2020: 132(5): 1114-1125. 
52. Kanai M, Sekiguchi H. Avoiding vessel laceration in thoracentesis: a role of vascular 
ultrasound with color Doppler. Chest 2015: 147(1): e5-e7. 
53. Adams FV, Galati V. M-mode ultrasonic localization of pleural effusion. Use in 
patients with nondiagnostic physical and roentgenographic examinations. JAMA 1978: 
239(17): 1761-1764. 
54. Gryminski J, Krakowka P, Lypacewicz G. The diagnosis of pleural effusion by 
ultrasonic and radiologic techniques. Chest 1976: 70(1): 33-37. 
55. Doust BD, Baum JK, Maklad NF, Doust VL. Ultrasonic evaluation of pleural opacities. 
Radiology 1975: 114(1): 135-140. 
56. Respiratory Medicine.  2019  [cited 2019 2/7]; Available from: 
https://www.jrcptb.org.uk/specialties/respiratory-medicine 
57. Kocijancic I. Diagnostic imaging of small amounts of pleural fluid: pleural effusion 
vs. physiologic pleural fluid. Collegium antropologicum 2007: 31(4): 1195-1199. 
58. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus 
radiography in the diagnosis of small pleural effusions. Journal of clinical ultrasound : JCU 
2003: 31(2): 69-74. 
59. Grimberg A, Shigueoka DC, Atallah AN, Ajzen S, Iared W. Diagnostic accuracy of 
sonography for pleural effusion: systematic review. Sao Paulo medical journal = Revista 
paulista de medicina 2010: 128(2): 90-95. 
60. Wu RG, Yuan A, Liaw YS, Chang DB, Yu CJ, Wu HD, Kuo SH, Luh KT, Yang PC. Image 
comparison of real-time gray-scale ultrasound and color Doppler ultrasound for use in 
diagnosis of minimal pleural effusion. American journal of respiratory and critical care 
medicine 1994: 150(2): 510-514. 
61. Kalokairinou-Motogna M, Maratou K, Paianid I, Soldatos T, Antipa E, Tsikkini A, 
Baltas CS. Application of color Doppler ultrasound in the study of small pleural effusion. 
Medical ultrasonography 2010: 12(1): 12-16. 
62. Stevic R, Colic N, Bascarevic S, Kostic M, Moskovljevic D, Savic M, Ercegovac M. 
Sonographic Indicators for Treatment Choice and Follow-Up in Patients with Pleural 
Effusion. Canadian respiratory journal 2018: 2018: 9761583. 
63. Svigals PZ, Chopra A, Ravenel JG, Nietert PJ, Huggins JT. The accuracy of pleural 
ultrasonography in diagnosing complicated parapneumonic pleural effusions. Thorax 2017: 
72(1): 94-95. 
64. Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective 
comparison of clinical examination with ultrasound. Chest 2003: 123(2): 436-441. 
65. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of 
malignant pleural effusion. Thorax 2009: 64(2): 139-143. 
66. Qureshi NR. Basic Physics of Diagnostic Ultrasound and Control ("Knobology"). In: 
Tobin CL, Lee YCG, Gleeson FV, Feller-Kopman D, Rahman NM, eds. Pleural Ultrasound for 
Clinicians. CRC Press, FL, USA, 2014. 
67. Chen HJ, Tu CY, Ling SJ, Chen W, Chiu KL, Hsia TC, Shih CM, Hsu WH. Sonographic 
appearances in transudative pleural effusions: not always an anechoic pattern. Ultrasound 
in medicine & biology 2008: 34(3): 362-369. 
68. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in 
determining the nature of pleural effusion: analysis of 320 cases. AJR American journal of 
roentgenology 1992: 159(1): 29-33. 
69. Hassan M, Rizk R, Essam H, Abouelnour A. Validation of equations for pleural 
effusion volume estimation by ultrasonography. Journal of ultrasound 2017: 20(4): 267-
271. 
70. Kataoka H. Ultrasound pleural effusion sign as a useful marker for identifying heart 
failure worsening in established heart failure patients during follow-up. Congestive heart 
failure 2012: 18(5): 272-277. 
71. Gurung P, Goldblatt M, Huggins JT, Doelken P, Nietert PJ, Sahn SA. Pleural fluid 
analysis and radiographic, sonographic, and echocardiographic characteristics of hepatic 
hydrothorax. Chest 2011: 140(2): 448-453. 
72. Sajadieh H, Afzali F, Sajadieh V, Sajadieh A. Ultrasound as an alternative to 
aspiration for determining the nature of pleural effusion, especially in older people. Annals 
of the New York Academy of Sciences 2004: 1019: 585-592. 
73. Evans AL, Gleeson FV. Radiology in pleural disease: state of the art. Respirology 
2004: 9(3): 300-312. 
74. Gorg C, Restrepo I, Schwerk WB. Sonography of malignant pleural effusion. 
European radiology 1997: 7(8): 1195-1198. 
75. Bugalho A, Ferreira D, Dias SS, Schuhmann M, Branco JC, Marques Gomes MJ, 
Eberhardt R. The diagnostic value of transthoracic ultrasonographic features in predicting 
malignancy in undiagnosed pleural effusions: a prospective observational study. 
Respiration; international review of thoracic diseases 2014: 87(4): 270-278. 
76. Chian CF, Su WL, Soh LH, Yan HC, Perng WC, Wu CP. Echogenic swirling pattern as a 
predictor of malignant pleural effusions in patients with malignancies. Chest 2004: 126(1): 
129-134. 
77. Lane AB, Petteys S, Ginn M, Nations JA. Clinical Importance of Echogenic Swirling 
Pleural Effusions. Journal of ultrasound in medicine : official journal of the American Institute 
of Ultrasound in Medicine 2016: 35(4): 843-847. 
78. Park CS, Chung WM, Lim MK, Cho CH, Suh CH, Chung WK. Transcatheter instillation 
of urokinase into loculated pleural effusion: analysis of treatment effect. AJR American 
journal of roentgenology 1996: 167(3): 649-652. 
79. Lin FC, Chou CW, Chang SC. Usefulness of the suspended microbubble sign in 
differentiating empyemic and nonempyemic hydropneumothorax. Journal of ultrasound in 
medicine : official journal of the American Institute of Ultrasound in Medicine 2001: 20(12): 
1341-1345. 
80. Lai YF, Su MC, Weng HH, Wu JT, Chiu CT. Sonographic septation: a predictor of 
sequelae of tuberculous pleurisy after treatment. Thorax 2009: 64(9): 806-809. 
81. Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and 
ultrasound in parapneumonic effusions and empyema. Clinical radiology 2000: 55(7): 542-
547. 
82. James CA, Braswell LE, Pezeshkmehr AH, Roberson PK, Parks JA, Moore MB. 
Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound 
grade correlation. Pediatric radiology 2017: 47(1): 89-95. 
83. Hallifax RJ, Rahman NM. Image Interpretation: Pleural Effusions. In: Tobin CL, Lee 
YCG, Gleeson FV, Feller-Kopman D, Rahman NM, eds. Pleural Ultrasound for Clinicians. CRC 
Press, FL, USA, 2014. 
84. Salamonsen MR, Lo AKC, Ng ACT, Bashirzadeh F, Wang WYS, Fielding DIK. Novel use 
of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage. 
Chest 2014: 146(5): 1286-1293. 
85. Lichtenstein DA. A Bedside Ultrasound Sign Ruling Out Pneumothorax in the 
Critically Ill. Lung Sliding. CHEST Journal 1995: 108(5): 1345. 
86. Lichtenstein D, Meziere G, Biderman P, Gepner A. The comet-tail artifact: an 
ultrasound sign ruling out pneumothorax. Intensive care medicine 1999: 25(4): 383-388. 
87. Lichtenstein D, Meziere G, Biderman P, Gepner A. The "lung point": an ultrasound 
sign specific to pneumothorax. Intensive care medicine 2000: 26(10): 1434-1440. 
88. Lichtenstein DA, Menu Y. A bedside ultrasound sign ruling out pneumothorax in the 
critically ill. Lung sliding. Chest 1995: 108(5): 1345-1348. 
89. Hallifax RJ, Talwar A, Wrightson JM, Edey A, Gleeson FV. State-of-the-art: 
Radiological investigation of pleural disease. Respir Med 2017: 124: 88-99. 
90. Slater A, Goodwin M, Anderson KE, Gleeson FV. COPD can mimic the appearance of 
pneumothorax on thoracic ultrasound. Chest 2006: 129(3): 545-550. 
91. Lichtenstein D, Meziere G, Biderman P, Gepner A. The comet-tail artifact: an 
ultrasound sign ruling out pneumothorax. Intensive Care Med 1999: 25(4): 383-388. 
92. Hew M, Tay TR. The efficacy of bedside chest ultrasound: from accuracy to 
outcomes. Eur Respir Rev 2016: 25(141): 230-246. 
93. Volpicelli G, Boero E, Sverzellati N, Cardinale L, Busso M, Boccuzzi F, Tullio M, 
Lamorte A, Stefanone V, Ferrari G, Veltri A, Frascisco MF. Semi-quantification of 
pneumothorax volume by lung ultrasound. Intensive Care Med 2014: 40(10): 1460-1467. 
94. Ding W, Shen Y, Yang J, He X, Zhang M. Diagnosis of pneumothorax by radiography 
and ultrasonography: a meta-analysis. Chest 2011: 140(4): 859-866. 
95. Alrajhi K, Woo MY, Vaillancourt C. Test characteristics of ultrasonography for the 
detection of pneumothorax: a systematic review and meta-analysis. Chest 2012: 141(3): 
703-708. 
96. Alrajab S, Youssef AM, Akkus NI, Caldito G. Pleural ultrasonography versus chest 
radiography for the diagnosis of pneumothorax: review of the literature and meta-analysis. 
Crit Care 2013: 17(5): R208. 
97. Ebrahimi A, Yousefifard M, Mohammad Kazemi H, Rasouli HR, Asady H, Moghadas 
Jafari A, Hosseini M. Diagnostic Accuracy of Chest Ultrasonography versus Chest 
Radiography for Identification of Pneumothorax: A Systematic Review and Meta-Analysis. 
Tanaffos 2014: 13(4): 29-40. 
98. Chung MJ, Goo JM, Im JG, Cho JM, Cho SB, Kim SJ. Value of high-resolution ultrasound 
in detecting a pneumothorax. Eur Radiol 2005: 15(5): 930-935. 
99. Reissig A, Kroegel C. Accuracy of transthoracic sonography in excluding post-
interventional pneumothorax and hydropneumothorax. Comparison to chest radiography. 
European journal of radiology 2005: 53(3): 463-470. 
100. Sartori S, Tombesi P, Trevisani L, Nielsen I, Tassinari D, Abbasciano V. Accuracy of 
transthoracic sonography in detection of pneumothorax after sonographically guided lung 
biopsy: prospective comparison with chest radiography. AJR Am J Roentgenol 2007: 188(1): 
37-41. 
101. Galbois A, Ait-Oufella H, JL B, Kofman T, Bottero J, Viennot S, Rabate C, Jabbouri S, 
Bouzeman A, B. G, Offenstadt G, Maury E. Pleural ultrasound compared with chest 
radiographic detection of pneumothorax resolution after drainage. Chest 2010: 138(3): 
648-655. 
102. Lichtenstein D, Meziere G, Biderman P, Gepner A, Barre O. The comet-tail artifact. An 
ultrasound sign of alveolar-interstitial syndrome. American journal of respiratory and 
critical care medicine 1997: 156(5): 1640-1646. 
103. Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung 
ultrasound in the critically ill. Chest 2015: 147(6): 1659-1670. 
104. Soldati G, Demi M. The use of lung ultrasound images for the differential diagnosis of 
pulmonary and cardiac interstitial pathology. Journal of ultrasound 2017: 20(2): 91-96. 
105. Volpicelli G. Lung sonography. J Ultrasound Med 2013: 32(1): 165-171. 
106. Dietrich CF, Mathis G, Blaivas M, Volpicelli G, Seibel A, Wastl D, Atkinson NS, Cui XW, 
Fan M, Yi D. Lung B-line artefacts and their use. J Thorac Dis 2016: 8(6): 1356-1365. 
107. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, 
Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, 
Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, 
Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T. International evidence-based 
recommendations for point-of-care lung ultrasound. Intensive Care Med 2012: 38(4): 577-
591. 
108. Gargani L, Doveri M, D'Errico L, Frassi F, Bazzichi ML, Delle Sedie A, Scali MC, Monti 
S, Mondillo S, Bombardieri S, Caramella D, Picano E. Ultrasound lung comets in systemic 
sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology 
2009: 48(11): 1382-1387. 
109. Barskova T, Gargani L, Guiducci S, Randone SB, Bruni C, Carnesecchi G, Conforti ML, 
Porta F, Pignone A, Caramella D, Picano E, Cerinic MM. Lung ultrasound for the screening of 
interstitial lung disease in very early systemic sclerosis. AnnRheumDis 2013: 72(3): 390-
395. 
110. Hasan AA, Makhlouf HA. B-lines: Transthoracic chest ultrasound signs useful in 
assessment of interstitial lung diseases. Ann Thorac Med 2014: 9(2): 99-103. 
111. Davidsen JR, Bendstrup E, Henriksen DP, Graumann O, Laursen CB. Lung ultrasound 
has limited diagnostic value in rare cystic lung diseases: a cross-sectional study. Eur Clin 
Respir J 2017: 4(1): 1330111. 
112. Davidsen JR, Schultz HHL, Henriksen DP, Iversen M, Kalhauge A, Carlsen J, Perch M, 
Graumann O, Laursen CB. Lung Ultrasound in the Assessment of Pulmonary Complications 
After Lung Transplantation. Ultraschall Med 2018. 
113. Gargani L. Interstitial syndrome. In: Laursen CB, Rahman NM, Volpicelli G, eds. . 
Thoracic Ultrasund [ERS Monograph] Sheffield, European Respiratory Society, 2018: pp. 75-
86 [https://doi.org/10.1183/2312508X.10006517]. 
114. DeFouw DO, Berendsen PB. Morphological changes in isolated perfused dog lungs 
after acute hydrostatic edema. Circ Res 1978: 43(1): 72-82. 
115. Maw AM, Hassanin A, Ho PM, McInnes MDF, Moss A, Juarez-Colunga E, Soni NJ, 
Miglioranza MH, Platz E, DeSanto K, Sertich AP, Salame G, Daugherty SL. Diagnostic 
Accuracy of Point-of-Care Lung Ultrasonography and Chest Radiography in Adults With 
Symptoms Suggestive of Acute Decompensated Heart Failure: A Systematic Review and 
Meta-analysis. JAMA network open 2019: 2(3): e190703. 
116. Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, Volpicelli G, Balzaretti P, 
Banderali A, Iacobucci A, Locatelli S, Casoli G, Stone MB, Maule MM, Baldi I, Merletti F, 
Cibinel GA, Baron P, Battista S, Buonafede G, Busso V, Conterno A, Del Rizzo P, Ferrera P, 
Pecetto PF, Moiraghi C, Morello F, Steri F, Ciccone G, Calasso C, Caserta MA, Civita M, Condo 
C, D'Alessandro V, Del Colle S, Ferrero S, Griot G, Laurita E, Lazzero A, Lo Curto F, 
Michelazzo M, Nicosia V, Palmari N, Ricchiardi A, Rolfo A, Rostagno R, Bar F, Boero E, 
Frascisco M, Micossi I, Mussa A, Stefanone V, Agricola R, Cordero G, Corradi F, Runzo C, 
Soragna A, Sciullo D, Vercillo D, Allione A, Artana N, Corsini F, Dutto L, Lauria G, Morgillo T, 
Tartaglino B, Bergandi D, Cassetta I, Masera C, Garrone M, Ghiselli G, Ausiello L, Barutta L, 
Bernardi E, Bono A, Forno D, Lamorte A, Lison D, Lorenzati B, Maggio E, Masi I, Maggiorotto 
M, Novelli G, Panero F, Perotto M, Ravazzoli M, Saglio E, Soardo F, Tizzani A, Tizzani P, 
Tullio M, Ulla M, Romagnoli E. Lung Ultrasound-Implemented Diagnosis of Acute 
Decompensated Heart Failure in the ED: A SIMEU Multicenter Study. Chest 2015: 148(1): 
202-210. 
117. Pivetta E, Goffi A, Nazerian P, Castagno D, Tozzetti C, Tizzani P, Tizzani M, Porrino G, 
Ferreri E, Busso V, Morello F, Paglieri C, Masoero M, Cassine E, Bovaro F, Grifoni S, Maule 
MM, Lupia E, Study Group on Lung Ultrasound from the M, Careggi H. Lung ultrasound 
integrated with clinical assessment for the diagnosis of acute decompensated heart failure 
in the emergency department: a randomized controlled trial. European journal of heart 
failure 2019: 21(6): 754-766. 
118. Bataille B, Riu B, Ferre F, Moussot PE, Mari A, Brunel E, Ruiz J, Mora M, Fourcade O, 
Genestal M, Silva S. Integrated use of bedside lung ultrasound and echocardiography in 
acute respiratory failure: a prospective observational study in ICU. Chest 2014: 146(6): 
1586-1593. 
119. Pesenti A, Musch G, Lichtenstein D, Mojoli F, Amato MBP, Cinnella G, Gattinoni L, 
Quintel M. Imaging in acute respiratory distress syndrome. Intensive Care Med 2016: 42(5): 
686-698. 
120. Bello G, Blanco P. Lung Ultrasonography for Assessing Lung Aeration in Acute 
Respiratory Distress Syndrome: A Narrative Review. J Ultrasound Med 2019: 38(1): 27-37. 
121. Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A. Ultrasound 
assessment for extravascular lung water in patients undergoing hemodialysis. Time course 
for resolution. Chest 2009: 135(6): 1433-1439. 
122. Panuccio V, Enia G, Tripepi R, Torino C, Garozzo M, Battaglia GG, Marcantoni C, 
Infantone L, Giordano G, De Giorgi ML, Lupia M, Bruzzese V, Zoccali C. Chest ultrasound and 
hidden lung congestion in peritoneal dialysis patients. Nephrology, dialysis, transplantation 
: official publication of the European Dialysis and Transplant Association - European Renal 
Association 2012: 27(9): 3601-3605. 
123. Miglioranza MH, Picano E, Badano LP, Sant'Anna R, Rover M, Zaffaroni F, Sicari R, 
Kalil RK, Leiria TL, Gargani L. Pulmonary congestion evaluated by lung ultrasound predicts 
decompensation in heart failure outpatients. Int J Cardiol 2017: 240: 271-278. 
124. Bouhemad B, Brisson H, Le-Guen M, Arbelot C, Lu Q, Rouby JJ. Bedside ultrasound 
assessment of positive end-expiratory pressure-induced lung recruitment. American 
journal of respiratory and critical care medicine 2011: 183(3): 341-347. 
125. Cortellaro F, Ceriani E, Spinelli M, Campanella C, Bossi I, Coen D, Casazza G, Cogliati 
C. Lung ultrasound for monitoring cardiogenic pulmonary edema. Intern Emerg Med 2017: 
12(7): 1011-1017. 
126. Trezzi M, Torzillo D, Ceriani E, Costantino G, Caruso S, Damavandi PT, Genderini A, 
Cicardi M, Montano N, Cogliati C. Lung ultrasonography for the assessment of rapid 
extravascular water variation: evidence from hemodialysis patients. Intern Emerg Med 
2013: 8(5): 409-415. 
127. Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, Nicholson AG, Ryerson CJ, 
Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro 
CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, 
Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, 
Sverzellati N, Swigris J, Valeyre D. An official American Thoracic Society/European 
Respiratory Society statement: Update of the international multidisciplinary classification 
of the idiopathic interstitial pneumonias. AmJ RespirCrit Care Med 2013: 188(6): 733-748. 
128. Pinal-Fernandez I, Pallisa-Nunez E, Selva-O'Callaghan A, Castella-Fierro E, Simeon-
Aznar CP, Fonollosa-Pla V, Vilardell-Tarres M. Pleural irregularity, a new ultrasound sign 
for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome. 
Clin Exp Rheumatol 2015: 33(4 Suppl 91): S136-141. 
129. Tardella M, Gutierrez M, Salaffi F, Carotti M, Ariani A, Bertolazzi C, Filippucci E, 
Grassi W. Ultrasound in the assessment of pulmonary fibrosis in connective tissue 
disorders: correlation with high-resolution computed tomography. J Rheumatol 2012: 
39(8): 1641-1647. 
130. Manolescu D, Davidescu L, Traila D, Oancea C, Tudorache V. The reliability of lung 
ultrasound in assessment of idiopathic pulmonary fibrosis. Clin Interv Aging 2018: 13: 437-
449. 
131. Wang Y, Gargani L, Barskova T, Furst DE, Cerinic MM. Usefulness of lung ultrasound 
B-lines in connective tissue disease-associated interstitial lung disease: a literature review. 
Arthritis Res Ther 2017: 19(1): 206. 
132. Soldati G, Demi M, Smargiassi A, Inchingolo R, Demi L. The role of ultrasound lung 
artifacts in the diagnosis of respiratory diseases. Expert Rev Respir Med 2019: 13(2): 163-
172. 
133. Lomoro P, Verde F, Zerboni F, Simonetti I, Borghi C, Fachinetti C, Natalizi A, 
Martegani A. COVID-19 pneumonia manifestations at the admission on chest ultrasound, 
radiographs, and CT: single-center study and comprehensive radiologic literature review. 
Eur J Radiol Open 2020: 7: 100231. 
134. Piscaglia F, Stefanini F, Cantisani V, Sidhu PS, Barr R, Berzigotti A, Chammas MC, 
Correas JM, Dietrich CF, Feinstein S, Huang P, Jenssen C, Kono Y, Kudo M, Liang P, Lyshchik 
A, Nolsoe C, Xie X, Tovoli F. Benefits, Open questions and Challenges of the use of 
Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international 
experts. Ultraschall in der Medizin 2020: 41(3): 228-236. 
135. Lu W, Zhang S, Chen B, Chen J, Xian J, Lin Y, Shan H, Su ZZ. A Clinical Study of 
Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-
19) by Bedside Ultrasound. Ultraschall in der Medizin 2020: 41(3): 300-307. 
136. Soldati G, Inchingolo R, Smargiassi A, Sher S, Nenna R, Inchingolo CD, Valente S. Ex 
vivo lung sonography: morphologic-ultrasound relationship. Ultrasound in medicine & 
biology 2012: 38(7): 1169-1179. 
137. Nazerian P, Volpicelli G, Vanni S, Gigli C, Betti L, Bartolucci M, Zanobetti M, Ermini 
FR, Iannello C, Grifoni S. Accuracy of lung ultrasound for the diagnosis of consolidations 
when compared to chest computed tomography. The American journal of emergency 
medicine 2015: 33(5): 620-625. 
138. Hew M, Corcoran JP, Harriss EK, Rahman NM, Mallett S. The diagnostic accuracy of 
chest ultrasound for CT-detected radiographic consolidation in hospitalised adults with 
acute respiratory failure: a systematic review. BMJ open 2015: 5(5): e007838. 
139. Weinberg B, Diakoumakis EE, Kass EG, Seife B, Zvi ZB. The air bronchogram: 
sonographic demonstration. AJR American journal of roentgenology 1986: 147(3): 593-595. 
140. Gehmacher O, Mathis G, Kopf A, Scheier M. Ultrasound imaging of pneumonia. 
Ultrasound in medicine & biology 1995: 21(9): 1119-1122. 
141. Reissig A, Kroegel C. Sonographic diagnosis and follow-up of pneumonia: a 
prospective study. Respiration; international review of thoracic diseases 2007: 74(5): 537-
547. 
142. Copetti R, Cattarossi L. Ultrasound diagnosis of pneumonia in children. La 
Radiologia medica 2008: 113(2): 190-198. 
143. Iuri D, De Candia A, Bazzocchi M. Evaluation of the lung in children with suspected 
pneumonia: usefulness of ultrasonography. La Radiologia medica 2009: 114(2): 321-330. 
144. Parlamento S, Copetti R, Di Bartolomeo S. Evaluation of lung ultrasound for the 
diagnosis of pneumonia in the ED. The American journal of emergency medicine 2009: 
27(4): 379-384. 
145. Sperandeo M, Carnevale V, Muscarella S, Sperandeo G, Varriale A, Filabozzi P, 
Piattelli ML, D'Alessandro V, Copetti M, Pellegrini F, Dimitri L, Vendemiale G. Clinical 
application of transthoracic ultrasonography in inpatients with pneumonia. European 
journal of clinical investigation 2011: 41(1): 1-7. 
146. Shah VP, Tunik MG, Tsung JW. Prospective Evaluation of Point-of-Care 
Ultrasonography for the Diagnosis of Pneumonia in Children and Young Adults. Archives of 
pediatrics & adolescent medicine 2012: 1-7. 
147. Mongodi S, Via G, Girard M, Rouquette I, Misset B, Braschi A, Mojoli F, Bouhemad B. 
Lung Ultrasound for Early Diagnosis of Ventilator-Associated Pneumonia. Chest 2016: 
149(4): 969-980. 
148. Orso D, Guglielmo N, Copetti R. Lung ultrasound in diagnosing pneumonia in the 
emergency department: a systematic review and meta-analysis. European journal of 
emergency medicine : official journal of the European Society for Emergency Medicine 2018: 
25(5): 312-321. 
149. Zanobetti M, Scorpiniti M, Gigli C, Nazerian P, Vanni S, Innocenti F, Stefanone VT, 
Savinelli C, Coppa A, Bigiarini S, Caldi F, Tassinari I, Conti A, Grifoni S, Pini R. Point-of-Care 
Ultrasonography for Evaluation of Acute Dyspnea in the ED. Chest 2017: 151(6): 1295-
1301. 
150. Mantuani D, Frazee BW, Fahimi J, Nagdev A. Point-of-Care Multi-Organ Ultrasound 
Improves Diagnostic Accuracy in Adults Presenting to the Emergency Department with 
Acute Dyspnea. The western journal of emergency medicine 2016: 17(1): 46-53. 
151. Jones BP, Tay ET, Elikashvili I, Sanders JE, Paul AZ, Nelson BP, Spina LA, Tsung JW. 
Feasibility and Safety of Substituting Lung Ultrasonography for Chest Radiography When 
Diagnosing Pneumonia in Children: A Randomized Controlled Trial. Chest 2016: 150(1): 
131-138. 
152. Miller LD, Joyner CR, Jr., Dudrick SJ, Eskin DJ. Clinical use of ultrasound in the early 
diagnosis of pulmonary embolism. Annals of surgery 1967: 166(3): 381-393. 
153. Mathis G, Metzler J, Feurstein M, Fussenegger D, Sutterlutti G. [Lung infarcts 
detected with ultrasonography]. Ultraschall in der Medizin 1990: 11(6): 281-283. 
154. Kroschel U, Seitz K, Reuss J, Rettenmaier G. [Sonographic imaging of lung emboli. 
Results of a prospective study]. Ultraschall in der Medizin 1991: 12(6): 263-268. 
155. Mathis G, Dirschmid K. Pulmonary infarction: sonographic appearance with 
pathologic correlation. European journal of radiology 1993: 17(3): 170-174. 
156. Mathis G, Bitschnau R, Gehmacher O, Scheier M, Kopf A, Schwarzler B, Amann T, 
Doringer W, Hergan K. Chest ultrasound in diagnosis of pulmonary embolism in 
comparison to helical CT. Ultraschall in der Medizin 1999: 20(2): 54-59. 
157. Reissig A, Heyne JP, Kroegel C. [Diagnosis of pulmonary embolism by transthoracic 
sonography. Sono-morphologic characterization of pulmonary lesions and comparison 
with spiral computed tomography]. Deutsche medizinische Wochenschrift (1946) 2000: 
125(49): 1487-1491. 
158. Reissig A. Sonography of Lung and Pleura in Pulmonary Embolism : 
Sonomorphologic Characterization and Comparison With Spiral CT Scanning. Chest 2001: 
120(6): 1977-1983. 
159. Lechleitner P, Riedl B, Raneburger W, Gamper G, Theurl A, Lederer A. Chest 
sonography in the diagnosis of pulmonary embolism: a comparison with MRI angiography 
and ventilation perfusion scintigraphy. Ultraschall in der Medizin 2002: 23(6): 373-378. 
160. Reissig A, Kroegel C. Transthoracic Ultrasound of Lung and Pleura in the Diagnosis 
of Pulmonary Embolism: A Novel Non-Invasive Bedside Approach. Respiration; 
international review of thoracic diseases 2003: 70(5): 441-452. 
161. Reißig A, Heyne J-P, Kroegel C. Ancillary lung parenchymal findings at spiral CT 
scanning in pulmonary embolism. Relationship to chest sonography. European journal of 
radiology 2004: 49(3): 250-257. 
162. Volpicelli G, Caramello V, Cardinale L, Cravino M. Diagnosis of radio-occult 
pulmonary conditions by real-time chest ultrasonography in patients with pleuritic pain. 
Ultrasound in medicine & biology 2008: 34(11): 1717-1723. 
163. Pfeil A, Reissig A, Heyne JP, Wolf G, Kaiser WA, Kroegel C, Hansch A. Transthoracic 
sonography in comparison to multislice computed tomography in detection of peripheral 
pulmonary embolism. Lung 2010: 188(1): 43-50. 
164. Volpicelli G, Cardinale L, Berchialla P, Mussa A, Bar F, Frascisco MF. A comparison of 
different diagnostic tests in the bedside evaluation of pleuritic pain in the ED. The American 
journal of emergency medicine 2012: 30(2): 317-324. 
165. Nazerian P, Vanni S, Volpicelli G, Gigli C, Zanobetti M, Bartolucci M, Ciavattone A, 
Lamorte A, Veltri A, Fabbri A, Grifoni S. Accuracy of point-of-care multiorgan 
ultrasonography for the diagnosis of pulmonary embolism. Chest 2013. 
166. Koenig S, Chandra S, Alaverdian A, Dibello C, Mayo PH, Narasimhan M. Ultrasound 
Assessment of Pulmonary Embolism in Patients Receiving Computerized Tomography 
Pulmonary Angiography. Chest 2013. 
167. Squizzato A, Rancan E, Dentali F, Bonzini M, Guasti L, Steidl L, Mathis G, Ageno W. 
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and 
meta-analysis. Journal of thrombosis and haemostasis : JTH 2013: 11(7): 1269-1278. 
168. Da Costa Rodrigues J, Alzuphar S, Combescure C, Le Gal G, Perrier A. Diagnostic 
characteristics of lower limb venous compression ultrasonography in suspected pulmonary 
embolism: a meta-analysis. J Thromb Haemost 2016: 14(9): 1765-1772. 
169. Fields JM, Davis J, Girson L, Au A, Potts J, Morgan CJ, Vetter I, Riesenberg LA. 
Transthoracic Echocardiography for Diagnosing Pulmonary Embolism: A Systematic 
Review and Meta-Analysis. J Am Soc Echocardiogr 2017: 30(7): 714-723 e714. 
170. Volpicelli G, Lamorte A, Tullio M, Cardinale L, Giraudo M, Stefanone V, Boero E, 
Nazerian P, Pozzi R, Frascisco MF. Point-of-care multiorgan ultrasonography for the 
evaluation of undifferentiated hypotension in the emergency department. Intensive care 
medicine 2013: 39(7): 1290-1298. 
171. Lin MS, Hwang JJ, Chong IW, Wang TH, Huang MS, Tsai MS, Chen KL. 
Ultrasonography of chest diseases: analysis of 154 cases. Gaoxiong yi xue ke xue za zhi = The 
Kaohsiung journal of medical sciences 1992: 8(10): 525-534. 
172. Yang PC, Luh KT, Chang DB, Yu CJ, Kuo SH, Wu HD. Ultrasonographic evaluation of 
pulmonary consolidation. The American review of respiratory disease 1992: 146(3): 757-
762. 
173. Lichtenstein DA, Lascols N, Prin S, Meziere G. The "lung pulse": an early ultrasound 
sign of complete atelectasis. Intensive care medicine 2003: 29(12): 2187-2192. 
174. Karabinis A, Saranteas T, Karakitsos D, Lichtenstein D, Poularas J, Yang C, Stefanadis 
C. The 'cardiac-lung mass' artifact: an echocardiographic sign of lung atelectasis and/or 
pleural effusion. Critical care 2008: 12(5): R122. 
175. Cavaliere F, Biasucci D, Costa R, Soave M, Addabbo G, Proietti R. Chest ultrasounds to 
guide manual reexpansion of a postoperative pulmonary atelectasis: a case report. Minerva 
anestesiologica 2011: 77(7): 750-753. 
176. Chen HJ, Yu YH, Tu CY, Chen CH, Hsia TC, Tsai KD, Shih CM, Hsu WH. Ultrasound in 
peripheral pulmonary air-fluid lesions. Color Doppler imaging as an aid in differentiating 
empyema and abscess. Chest 2009: 135(6): 1426-1432. 
177. Suzuki N, Saitoh T, Kitamura S. Tumor invasion of the chest wall in lung cancer: 
diagnosis with US. Radiology 1993: 187(1): 39-42. 
178. Yuan A, Chang DB, Yu CJ, Kuo SH, Luh KT, Yang PC. Color Doppler sonography of 
benign and malignant pulmonary masses. AJR American journal of roentgenology 1994: 
163(3): 545-549. 
179. Chira R, Chira A, Mircea PA. Intrathoracic tumors in contact with the chest wall--
ultrasonographic and computed tomography comparative evaluation. Medical 
ultrasonography 2012: 14(2): 115-119. 
180. Hyacinthe AC, Broux C, Francony G, Genty C, Bouzat P, Jacquot C, Albaladejo P, 
Ferretti GR, Bosson JL, Payen JF. Diagnostic accuracy of ultrasonography in the acute 
assessment of common thoracic lesions after trauma. Chest 2012: 141(5): 1177-1183. 
181. Wustner A, Gehmacher O, Hammerle S, Schenkenbach C, Hafele H, Mathis G. 
[Ultrasound diagnosis in blunt thoracic trauma]. Ultraschall in der Medizin 2005: 26(4): 
285-290. 
182. Lin FC, Chou CW, Chang SC. Differentiating pyopneumothorax and peripheral lung 
abscess: chest ultrasonography. The American journal of the medical sciences 2004: 327(6): 
330-335. 
183. Via G, Storti E, Gulati G, Neri L, Mojoli F, Braschi A. Lung ultrasound in the ICU: from 
diagnostic instrument to respiratory monitoring tool. Minerva Anestesiol 2012: 78(11): 
1282-1296. 
184. Arbelot C, Ferrari F, Bouhemad B, Rouby JJ. Lung ultrasound in acute respiratory 
distress syndrome and acute lung injury. Current opinion in critical care 2008: 14(1): 70-74. 
185. Soummer A, Perbet S, Brisson H, Arbelot C, Constantin JM, Lu Q, Rouby JJ, Lung 
Ultrasound Study G. Ultrasound assessment of lung aeration loss during a successful 
weaning trial predicts postextubation distress*. Critical care medicine 2012: 40(7): 2064-
2072. 
186. Haddam M, Zieleskiewicz L, Perbet S, Baldovini A, Guervilly C, Arbelot C, Noel A, 
Vigne C, Hammad E, Antonini F, Lehingue S, Peytel E, Lu Q, Bouhemad B, Golmard JL, 
Langeron O, Martin C, Muller L, Rouby JJ, Constantin JM, Papazian L, Leone M, Network 
CAEC, AzuRea Collaborative N. Lung ultrasonography for assessment of oxygenation 
response to prone position ventilation in ARDS. Intensive Care Med 2016: 42(10): 1546-
1556. 
187. Prat G, Guinard S, Bizien N, Nowak E, Tonnelier JM, Alavi Z, Renault A, Boles JM, 
L'Her E. Can lung ultrasonography predict prone positioning response in acute respiratory 
distress syndrome patients? J Crit Care 2016: 32: 36-41. 
188. Mongodi S, Bouhemad B, Orlando A, Stella A, Tavazzi G, Via G, Iotti GA, Braschi A, 
Mojoli F. Modified Lung Ultrasound Score for Assessing and Monitoring Pulmonary 
Aeration. Ultraschall Med 2017: 38(5): 530-537. 
189. Chiumello D, Mongodi S, Algieri I, Vergani GL, Orlando A, Via G, Crimella F, Cressoni 
M, Mojoli F. Assessment of Lung Aeration and Recruitment by CT Scan and Ultrasound in 
Acute Respiratory Distress Syndrome Patients. Crit Care Med 2018: 46(11): 1761-1768. 
190. Haji K, Haji D, Canty DJ, Royse AG, Green C, Royse CF. The impact of heart, lung and 
diaphragmatic ultrasound on prediction of failed extubation from mechanical ventilation in 
critically ill patients: a prospective observational pilot study. Crit Ultrasound J 2018: 10(1): 
13. 
191. Cardenas LZ, Santana PV, Caruso P, Ribeiro de Carvalho CR, Pereira de Albuquerque 
AL. Diaphragmatic Ultrasound Correlates with Inspiratory Muscle Strength and Pulmonary 
Function in Healthy Subjects. Ultrasound in medicine & biology 2018: 44(4): 786-793. 
192. Holtzhausen S, Unger M, Lupton-Smith A, Hanekom S. An investigation into the use 
of ultrasound as a surrogate measure of diaphragm function. Heart & lung : the journal of 
critical care 2018: 47(4): 418-424. 
193. Caleffi-Pereira M, Pletsch-Assuncao R, Cardenas LZ, Santana PV, Ferreira JG, Iamonti 
VC, Caruso P, Fernandez A, de Carvalho CRR, Albuquerque ALP. Unilateral diaphragm 
paralysis: a dysfunction restricted not just to one hemidiaphragm. BMC Pulm Med 2018: 
18(1): 126. 
194. Houston JG, Fleet M, Cowan MD, McMillan NC. Comparison of ultrasound with 
fluoroscopy in the assessment of suspected hemidiaphragmatic movement abnormality. 
Clinical radiology 1995: 50(2): 95-98. 
195. Skaarup SH, Lokke A, Laursen CB. The Area method: a new method for ultrasound 
assessment of diaphragmatic movement. Crit Ultrasound J 2018: 10(1): 15. 
196. Ye X, Xiao H, Bai W, Liang Y, Chen M, Zhang S. Two-dimensional strain ultrasound 
speckle tracking as a novel approach for the evaluation of right hemidiaphragmatic 
longitudinal deformation. Exp Ther Med 2013: 6(2): 368-372. 
197. Orde SR, Boon AJ, Firth DG, Villarraga HR, Sekiguchi H. Diaphragm assessment by 
two dimensional speckle tracking imaging in normal subjects. BMC Anesthesiol 2016: 16(1): 
43. 
198. Ouanes-Besbes L, Dachraoui F, Ouanes I, Bouneb R, Jalloul F, Dlala M, Najjar MF, 
Abroug F. NT-proBNP levels at spontaneous breathing trial help in the prediction of post-
extubation respiratory distress. Intensive care medicine 2012: 38(5): 788-795. 
199. Frutos-Vivar F, Ferguson ND, Esteban A, Epstein SK, Arabi Y, Apezteguia C, Gonzalez 
M, Hill NS, Nava S, D'Empaire G, Anzueto A. Risk factors for extubation failure in patients 
following a successful spontaneous breathing trial. Chest 2006: 130(6): 1664-1671. 
200. Llamas-Alvarez AM, Tenza-Lozano EM, Latour-Perez J. Diaphragm and Lung 
Ultrasound to Predict Weaning Outcome: Systematic Review and Meta-Analysis. Chest 
2017: 152(6): 1140-1150. 
201. Li C, Li X, Han H, Cui H, Wang G, Wang Z. Diaphragmatic ultrasonography for 
predicting ventilator weaning: A meta-analysis. Medicine (Baltimore) 2018: 97(22): 
e10968. 
202. Scarlata S, Mancini D, Laudisio A, Benigni A, Antonelli Incalzi R. Reproducibility and 
Clinical Correlates of Supine Diaphragmatic Motion Measured by M-Mode Ultrasonography 
in Healthy Volunteers. Respiration; international review of thoracic diseases 2018: 96(3): 
259-266. 
203. Brown C, Tseng SC, Mitchell K, Roddey T. Body Position Affects Ultrasonographic 
Measurement of Diaphragm Contractility. Cardiopulm Phys Ther J 2018: 29(4): 166-172. 
204. Scarlata S, Mancini D, Laudisio A, Raffaele AI. Reproducibility of diaphragmatic 
thickness measured by M-mode ultrasonography in healthy volunteers. Respir Physiol 
Neurobiol 2019: 260: 58-62. 
205. Pirompanich P, Romsaiyut S. Use of diaphragm thickening fraction combined with 
rapid shallow breathing index for predicting success of weaning from mechanical 
ventilator in medical patients. J Intensive Care 2018: 6: 6. 
206. Dhungana A, Khilnani G, Hadda V, Guleria R. Reproducibility of diaphragm thickness 
measurements by ultrasonography in patients on mechanical ventilation. World J Crit Care 
Med 2017: 6(4): 185-189. 
207. Vivier E, Muller M, Putegnat JB, Steyer J, Barrau S, Boissier F, Bourdin G, Mekontso-
Dessap A, Levrat A, Pommier C, Thille AW. Inability of Diaphragm Ultrasound to Predict 
Extubation Failure: A Multicenter Study. Chest 2019: 155(6): 1131-1139. 
208. Umbrello M, Mistraletti G, Galimberti A, Piva IR, Cozzi O, Formenti P. Drainage of 
pleural effusion improves diaphragmatic function in mechanically ventilated patients. Crit 
Care Resusc 2017: 19(1): 64-70. 
209. Garske LA, Kunarajah K, Zimmerman PV, Adams L, Stewart IB. In patients with 
unilateral pleural effusion, restricted lung inflation is the principal predictor of increased 
dyspnoea. PloS one 2018: 13(10): e0202621. 
210. Wang LM, Cherng JM, Wang JS. Improved lung function after thoracocentesis in 
patients with paradoxical movement of a hemidiaphragm secondary to a large pleural 
effusion. Respirology 2007: 12(5): 719-723. 
211. Muruganandan S, Azzopardi M, Thomas R, Fitzgerald DB, Kuok YJ, Cheah HM, Read 
CA, Budgeon CA, Eastwood PR, Jenkins S, Singh B, Murray K, Lee YCG. The Pleural Effusion 
And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic 
pleural effusion. The European respiratory journal : official journal of the European Society 
for Clinical Respiratory Physiology 2020: 55(5). 
212. Hida T, Yamada Y, Ueyama M, Araki T, Nishino M, Kurosaki A, Jinzaki M, Honda H, 
Hatabu H, Kudoh S. Decreased and slower diaphragmatic motion during forced breathing in 
severe COPD patients: Time-resolved quantitative analysis using dynamic chest 
radiography with a flat panel detector system. European journal of radiology 2019: 112: 28-
36. 
213. Souza RMP, Cardim AB, Maia TO, Rocha LG, Bezerra SD, Marinho PEM. Inspiratory 
muscle strength, diaphragmatic mobility, and body composition in chronic obstructive 
pulmonary disease. Physiother Res Int 2019: 24(2): e1766. 
214. Antenora F, Fantini R, Iattoni A, Castaniere I, Sdanganelli A, Livrieri F, Tonelli R, 
Zona S, Monelli M, Clini EM, Marchioni A. Prevalence and outcomes of diaphragmatic 
dysfunction assessed by ultrasound technology during acute exacerbation of COPD: A pilot 
study. Respirology 2017: 22(2): 338-344. 
215. Marchioni A, Castaniere I, Tonelli R, Fantini R, Fontana M, Tabbi L, Viani A, Giaroni F, 
Ruggieri V, Cerri S, Clini E. Ultrasound-assessed diaphragmatic impairment is a predictor of 
outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease 
undergoing noninvasive ventilation. Critical care 2018: 22(1): 109. 
216. Okura K, Kawagoshi A, Iwakura M, Sugawara K, Takahashi H, Kashiwagura T, 
Homma M, Satake M, Shioya T. Contractile capability of the diaphragm assessed by 
ultrasonography predicts nocturnal oxygen saturation in COPD. Respirology 2017: 22(2): 
301-306. 
217. Harlaar L, Ciet P, van der Ploeg AT, Brusse E, van der Beek N, Wielopolski PA, de 
Bruijne M, Tiddens H, van Doorn PA. Imaging of respiratory muscles in neuromuscular 
disease: A review. Neuromuscular disorders : NMD 2018: 28(3): 246-256. 
218. Laviola M, Priori R, D'Angelo MG, Aliverti A. Assessment of diaphragmatic thickness 
by ultrasonography in Duchenne muscular dystrophy (DMD) patients. PloS one 2018: 
13(7): e0200582. 
219. Hiwatani Y, Sakata M, Miwa H. Ultrasonography of the diaphragm in amyotrophic 
lateral sclerosis: clinical significance in assessment of respiratory functions. Amyotroph 
Lateral Scler Frontotemporal Degener 2013: 14(2): 127-131. 
220. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Stoylen A, 
Ihlen H, Lima JA, Smiseth OA, Slordahl SA. Noninvasive myocardial strain measurement by 
speckle tracking echocardiography: validation against sonomicrometry and tagged 
magnetic resonance imaging. Journal of the American College of Cardiology 2006: 47(4): 
789-793. 
221. Diacon AH. Accuracy of Pleural Puncture Sites: A Prospective Comparison of Clinical 
Examination With Ultrasound. Chest 2003: 123(2): 436-441. 
222. Duncan DR, Morgenthaler TI, Ryu JH, Daniels CE. Reducing iatrogenic risk in 
thoracentesis: establishing best practice via experiential training in a zero-risk 
environment. Chest 2009: 135(5): 1315-1320. 
223. Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves 
the cost of care among patients undergoing thoracentesis and paracentesis. Chest 2013: 
143(2): 532-538. 
224. Millington SJ, Koenig S. Better With Ultrasound: Pleural Procedures in Critically Ill 
Patients. Chest 2018: 153(1): 224-232. 
225. Bhatnagar R, Corcoran JP, Maldonado F, Feller-Kopman D, Janssen J, Astoul P, 
Rahman NM. Advanced medical interventions in pleural disease. Eur Respir Rev 2016: 
25(140): 199-213. 
226. Psallidas I, Yousuf A, Talwar A, Hallifax RJ, Mishra EK, Corcoran JP, Ali N, Rahman 
NM. Assessment of patient-reported outcome measures in pleural interventions. BMJ Open 
Respir Res 2017: 4(1): e000171. 
227. Shojaee S, Argento AC. Ultrasound-guided pleural access. Semin Respir Crit Care Med 
2014: 35(6): 693-705. 
228. Salamonsen M, Dobeli K, McGrath D, Readdy C, Ware R, Steinke K, Fielding D. 
Physician-performed ultrasound can accurately screen for a vulnerable intercostal artery 
prior to chest drainage procedures. Respirology 2013: 18(6): 942-947. 
229. Corcoran JP, Psallidas I, Wrightson JM, Hallifax RJ, Rahman NM. Pleural procedural 
complications: prevention and management. Journal of thoracic disease 2015: 7(6): 1058-
1067. 
230. Rahman NM, Pepperell J, Rehal S, Saba T, Tang A, Ali N, West A, Hettiarachchi G, 
Mukherjee D, Samuel J, Bentley A, Dowson L, Miles J, Ryan CF, Yoneda KY, Chauhan A, 
Corcoran JP, Psallidas I, Wrightson JM, Hallifax R, Davies HE, Lee YC, Dobson M, Hedley EL, 
Seaton D, Russell N, Chapman M, McFadyen BM, Shaw RA, Davies RJ, Maskell NA, Nunn AJ, 
Miller RF. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain 
Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The 
TIME1 Randomized Clinical Trial. JAMA : the journal of the American Medical Association 
2015: 314(24): 2641-2653. 
231. Rahman NM, Maskell NA, Davies CW, Hedley EL, Nunn AJ, Gleeson FV, Davies RJ. The 
relationship between chest tube size and clinical outcome in pleural infection. Chest 2010: 
137(3): 536-543. 
232. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, 
Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ, First Multicenter Intrapleural 
Sepsis Trial G. U.K. Controlled trial of intrapleural streptokinase for pleural infection. The 
New England journal of medicine 2005: 352(9): 865-874. 
233. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies 
CW, Ali N, Kinnear W, Bentley A, Kahan BC, Wrightson JM, Davies HE, Hooper CE, Lee YC, 
Hedley EL, Crosthwaite N, Choo L, Helm EJ, Gleeson FV, Nunn AJ, Davies RJ. Intrapleural use 
of tissue plasminogen activator and DNase in pleural infection. The New England journal of 
medicine 2011: 365(6): 518-526. 
234. Hallifax RJ, Psallidas I, Rahman NM. Chest Drain Size: the Debate Continues. Curr 
Pulmonol Rep 2017: 6(1): 26-29. 
235. Thethi I, Ramirez S, Shen W, Zhang D, Mohamad M, Kaphle U, Kheir F. Effect of chest 
tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of 
randomized controlled trials. Journal of thoracic disease 2018: 10(1): 355-362. 
236. Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, 
Mustafa RA, Bishop LJ, Ahmed L, West A, Holme J, Evison M, Munavvar M, Sivasothy P, 
Herre J, Cooper D, Roberts M, Guhan A, Hooper C, Walters J, Saba TS, Chakrabarti B, 
Gunatilake S, Psallidas I, Walker SP, Bibby AC, Smith S, Stadon LJ, Zahan-Evans NJ, Lee YCG, 
Harvey JE, Rahman NM, Miller RF, Maskell NA. Outpatient Talc Administration by 
Indwelling Pleural Catheter for Malignant Effusion. The New England journal of medicine 
2018: 378(14): 1313-1322. 
237. Feller-Kopman D, Parker MJ, Schwartzstein RM. Assessment of pleural pressure in 
the evaluation of pleural effusions. Chest 2009: 135(1): 201-209. 
238. Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJ, Downer NJ, Gleeson FV, Howes 
TQ, Treasure T, Singh S, Phillips GD, British Thoracic Society Pleural Disease Guideline G. 
Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. 
Thorax 2010: 65 Suppl 2: ii54-60. 
239. de Fonseka D, Bhatnagar R, Maskell NA. Local Anaesthetic (Medical) Thoracoscopy 
Services in the UK. Respiration; international review of thoracic diseases 2018: 96(6): 560-
563. 
240. Corcoran JP, Psallidas I, Hallifax RJ, Talwar A, Sykes A, Rahman NM. Ultrasound-
guided pneumothorax induction prior to local anaesthetic thoracoscopy. Thorax 2015: 
70(9): 906-908. 
241. Marchetti G, Valsecchi A, Indellicati D, Arondi S, Trigiani M, Pinelli V. Ultrasound-
guided medical thoracoscopy in the absence of pleural effusion. Chest 2015: 147(4): 1008-
1012. 
242. Meena N, Bartter T. Ultrasound-guided Percutaneous Needle Aspiration by 
Pulmonologists: A Study of Factors With Impact on Procedural Yield and Complications. 
Journal of bronchology & interventional pulmonology 2015: 22(3): 204-208. 
243. Laursen CB, Naur TM, Bodtger U, Colella S, Naqibullah M, Minddal V, Konge L, 
Davidsen JR, Hansen NC, Graumann O, Clementsen PF. Ultrasound-guided Lung Biopsy in 
the Hands of Respiratory Physicians: Diagnostic Yield and Complications in 215 
Consecutive Patients in 3 Centers. Journal of bronchology & interventional pulmonology 
2016: 23(3): 220-228. 
244. Lee MH, Lubner MG, Hinshaw JL, Pickhardt PJ. Ultrasound Guidance Versus CT 
Guidance for Peripheral Lung Biopsy: Performance According to Lesion Size and Pleural 
Contact. AJR American journal of roentgenology 2018: 210(3): W110-W117. 
245. Sconfienza LM, Mauri G, Grossi F, Truini M, Serafini G, Sardanelli F, Murolo C. Pleural 
and Peripheral Lung Lesions: Comparison of US- and CT-guided Biopsy. Radiology 2012. 
246. Yamamoto N, Watanabe T, Yamada K, Nakai T, Suzumura T, Sakagami K, Yoshimoto 
N, Sato K, Tanaka H, Mitsuoka S, Asai K, Kimura T, Kanazawa H, Hirata K, Kawaguchi T. 
Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral 
lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy. 
Journal of thoracic disease 2019: 11(3): 936-943. 
247. Gorg C, Kring R, Bert T. Transcutaneous contrast-enhanced sonography of 
peripheral lung lesions. AJR American journal of roentgenology 2006: 187(4): W420-429. 
248. Cao BS, Wu JH, Li XL, Deng J, Liao GQ. Sonographically guided transthoracic biopsy of 
peripheral lung and mediastinal lesions: role of contrast-enhanced sonography. Journal of 
ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 
2011: 30(11): 1479-1490. 
249. Laursen CB, Graumann O, Moller TV, Davidsen JR. Contrast-enhanced Ultrasound-
guided Transthoracic Lung Biopsy. American journal of respiratory and critical care 
medicine 2016: 194(5): e5-6. 
250. Faruk T, Islam MK, Arefin S, Haq MZ. The Journey of Elastography: Background, 
Current Status, and Future Possibilities in Breast Cancer Diagnosis. Clin Breast Cancer 
2015: 15(5): 313-324. 
251. Sperandeo M, Trovato FM, Dimitri L, Catalano D, Simeone A, Martines GF, Piscitelli 
AP, Trovato GM. Lung transthoracic ultrasound elastography imaging and guided biopsies 
of subpleural cancer: a preliminary report. Acta radiologica (Stockholm, Sweden : 1987) 
2015: 56(7): 798-805. 
252. Fultz PJ, Feins RH, Strang JG, Wandtke JC, Johnstone DW, Watson TJ, Gottlieb RH, 
Voci SL, Rubens DJ. Detection and diagnosis of nonpalpable supraclavicular lymph nodes in 
lung cancer at CT and US. Radiology 2002: 222(1): 245-251. 
253. van Overhagen H, Brakel K, Heijenbrok MW, van Kasteren JH, van de Moosdijk CN, 
Roldaan AC, van Gils AP, Hansen BE. Metastases in supraclavicular lymph nodes in lung 
cancer: assessment with palpation, US, and CT. Radiology 2004: 232(1): 75-80. 
254. Prosch H, Strasser G, Sonka C, Oschatz E, Mashaal S, Mohn-Staudner A, Mostbeck GH. 
Cervical ultrasound (US) and US-guided lymph node biopsy as a routine procedure for 
staging of lung cancer. Ultraschall in der Medizin 2007: 28(6): 598-603. 
255. Ahmed M, Daneshvar C, Breen D. Ultrasound-Guided Cervical Lymph Node Sampling 
Performed by Respiratory Physicians. Biomed Hub 2019: 4(2): 1-6. 
256. Ahmed M, Daneshvar C, Breen D. Neck Ultrasound for the Detection of Cervical 
Lymphadenopathy in Sarcoidosis: An Alternative to Endobronchial Ultrasound. Journal of 
bronchology & interventional pulmonology 2019: 26(3): 225-227. 
257. Fahim A, Qasim MM, Rosewarne D. Neck as mediastinal extension: Diagnosis of 
sarcoidosis by core biopsy of cervical lymph nodes. Clin Respir J 2020: 14(1): 16-20. 
258. Kim DW, Jung SJ, Ha TK, Park HK. Individual and combined diagnostic accuracy of 
ultrasound diagnosis, ultrasound-guided fine-needle aspiration and polymerase chain 
reaction in identifying tuberculous lymph nodes in the neck. Ultrasound in medicine & 
biology 2013: 39(12): 2308-2314. 
259. Ebrahimi A, Yousefifard M, Mohammad Kazemi H, Rasouli HR, Asady H, Moghadas 
Jafari A, Hosseini M. Diagnostic Accuracy of Chest Ultrasonography versus Chest 
Radiography for Identification of Pneumothorax: A Systematic Review and Meta-Analysis. 
Tanaffos 2014: 13(4): 29-40. 
260. Chavez MA, Shams N, Ellington LE, Naithani N, Gilman RH, Steinhoff MC, Santosham 
M, Black RE, Price C, Gross M, Checkley W. Lung ultrasound for the diagnosis of pneumonia 
in adults: a systematic review and meta-analysis. Respir Res 2014: 15: 50. 
261. Staub LJ, Mazzali Biscaro RR, Kaszubowski E, Maurici R. Lung Ultrasound for the 
Emergency Diagnosis of Pneumonia, Acute Heart Failure, and Exacerbations of Chronic 
Obstructive Pulmonary Disease/Asthma in Adults: A Systematic Review and Meta-analysis. 
J Emerg Med 2019: 56(1): 53-69. 
262. Pietersen PI, Madsen KR, Graumann O, Konge L, Nielsen BU, Laursen CB. Lung 
ultrasound training: a systematic review of published literature in clinical lung ultrasound 
training. Crit Ultrasound J 2018: 10(1): 23. 
263. Breitkreutz R, Dutine M, Scheiermann P, Hempel D, Kujumdshiev S, Ackermann H, 
Seeger FH, Seibel A, Walcher F, Hirche TO. Thorax, trachea, and lung ultrasonography in 
emergency and critical care medicine: assessment of an objective structured training 
concept. Emerg Med Int 2013: 2013: 312758. 
264. Hulett CS, Pathak V, Katz JN, Montgomery SP, Chang LH. Development and 
preliminary assessment of a critical care ultrasound course in an adult pulmonary and 
critical care fellowship program. Ann Am Thorac Soc 2014: 11(5): 784-788. 
265. Radiologists TRCo. Ultrasound training recommendations for medical and surgical 
specialities - Appendix 6: Thoracic ultrasound. Clinical Radiology 2017: 3rd Ed. 
266. Biology EFoSfUiMa. Minimum tranining requirements for the practice of medical 
ultrasound in Europe - Appendix 11: Thoracic ultrasound. 2009. 
267. Konge LL, L. Simulation-based training of surgical skills. Perspect Med Educ 2016: 
5(1): 3-4. 
268. McGaghie WC, Issenberg SB, Petrusa ER, Scalese RJ. A critical review of simulation-
based medical education research: 2003-2009. Med Educ 2010: 44(1): 50-63. 
269. Konge L, Clementsen PF, Ringsted C, Minddal V, Larsen KR, Annema JT. Simulator 
training for endobronchial ultrasound: a randomised controlled trial. The European 
respiratory journal : official journal of the European Society for Clinical Respiratory 
Physiology 2015: 46(4): 1140-1149. 
270. Kemp SV, El Batrawy SH, Harrison RN, Skwarski K, Munavvar M, Rosell A, Cusworth 
K, Shah PL. Learning curves for endobronchial ultrasound using cusum analysis. Thorax 
2010: 65(6): 534-538. 
271. Noble VE, Lamhaut L, Capp R, Bosson N, Liteplo A, Marx JS, Carli P. Evaluation of a 
thoracic ultrasound training module for the detection of pneumothorax and pulmonary 
edema by prehospital physician care providers. BMC medical education 2009: 9: 3. 
272. Oveland NP, Sloth E, Andersen G, Lossius HM. A porcine pneumothorax model for 
teaching ultrasound diagnostics. Acad Emerg Med 2012: 19(5): 586-592. 
273. Cuca C, Scheiermann P, Hempel D, Via G, Seibel A, Barth M, Hirche TO, Walcher F, 
Breitkreutz R. Assessment of a new e-learning system on thorax, trachea, and lung 
ultrasound. Emerg Med Int 2013: 2013: 145361. 
274. See KC, Ong V, Wong SH, Leanda R, Santos J, Taculod J, Phua J, Teoh CM. Lung 
ultrasound training: curriculum implementation and learning trajectory among respiratory 
therapists. Intensive care medicine 2016: 42(1): 63-71. 
275. Sanchez-de-Toledo J, Renter-Valdovinos L, Esteves M, Fonseca C, Villaverde I, Rosal 
M. Teaching Chest Ultrasound in an Experimental Porcine Model. Pediatr Emerg Care 2016: 
32(11): 768-772. 
276. Edrich T, Stopfkuchen-Evans M, Scheiermann P, Heim M, Chan W, Stone MB, Dankl 
D, Aichner J, Hinzmann D, Song P, Szabo AL, Frendl G, Vlassakov K, Varelmann D. A 
Comparison of Web-Based with Traditional Classroom-Based Training of Lung Ultrasound 
for the Exclusion of Pneumothorax. Anesth Analg 2016: 123(1): 123-128. 
277. Pietersen PI, Konge L, Madsen KR, Bendixen M, Maskell NA, Rahman N, Graumann O, 
Laursen CB. Development of and Gathering Validity Evidence for a Theoretical Test in 
Thoracic Ultrasound. Respiration 2019: 98(3): 221-229. 
278. Connolly K, Beier L, Langdorf MI, Anderson CL, Fox JC. Ultrafest: a novel approach to 
ultrasound in medical education leads to improvement in written and clinical 
examinations. West J Emerg Med 2015: 16(1): 143-148. 
279. Dinh VA, Giri PC, Rathinavel I, Nguyen E, Hecht D, Dorotta I, Nguyen HB, Chrissian 
AA. Impact of a 2-Day Critical Care Ultrasound Course during Fellowship Training: A Pilot 
Study. Crit Care Res Pract 2015: 2015: 675041. 
280. Heiberg J, Hansen LS, Wemmelund K, Sorensen AH, Ilkjaer C, Cloete E, Nolte D, Roodt 
F, Dyer R, Swanevelder J, Sloth E. Point-of-Care Clinical Ultrasound for Medical Students. 
Ultrasound Int Open 2015: 1(2): E58-66. 
281. Greenstein YY, Littauer R, Narasimhan M, Mayo PH, Koenig SJ. Effectiveness of a 
Critical Care Ultrasonography Course. Chest 2017: 151(1): 34-40. 
282. Abbasi S, Farsi D, Hafezimoghadam P, Fathi M, Zare MA. Accuracy of emergency 
physician-performed ultrasound in detecting traumatic pneumothorax after a 2-h training 
course. Eur J Emerg Med 2013: 20(3): 173-177. 
283. Salamonsen M, McGrath D, Steiler G, Ware R, Colt H, Fielding D. A new instrument to 
assess physician skill at thoracic ultrasound, including pleural effusion markup. Chest 2013: 
144(3): 930-934. 
284. Pietersen PI, Konge L, Graumann O, Nielsen BU, Laursen CB. Developing and 
Gathering Validity Evidence for a Simulation-Based Test of Competencies in Lung 
Ultrasound. Respiration 2018: 1-8. 
285. Millington SJ, Arntfield RT, Guo RJ, Koenig S, Kory P, Noble V, Mallemat H, 
Schoenherr JR. The Assessment of Competency in Thoracic Sonography (ACTS) scale: 
validation of a tool for point-of-care ultrasound. Crit Ultrasound J 2017: 9(1): 25. 
286. Skaarup SH, Laursen CB, Bjerrum AS, Hilberg O. Objective and Structured 
Assessment of Lung Ultrasound Competence. A Multispecialty Delphi Consensus and 
Construct Validity Study. Ann Am Thorac Soc 2017: 14(4): 555-560. 
287. Williamson JP, Twaddell SH, Lee YC, Salamonsen M, Hew M, Fielding D, Nguyen P, 
Steinfort D, Hopkins P, Smith N, Grainge C. Thoracic ultrasound recognition of competence: 
A position paper of the Thoracic Society of Australia and New Zealand. Respirology 2017: 
22(2): 405-408. 
288. Evison M, Blyth KG, Bhatnagar R, Corcoran J, Saba T, Duncan T, Hallifax R, Ahmed L, 
West A, Pepperell JCT, Roberts M, Sivasothy P, Psallidas I, Clive AO, Latham J, Stanton AE, 
Maskell N, Rahman N. Providing safe and effective pleural medicine services in the UK: an 
aspirational statement from UK pleural physicians. BMJ Open Respir Res 2018: 5(1): 
e000307. 
289. Downing SM YR. Assessment in Health Profesions Education Routledge - Taylor & 
Francis Group, New York, London, 2009. 
290. Howard ZD, Noble VE, Marill KA, Sajed D, Rodrigues M, Bertuzzi B, Liteplo AS. 
Bedside Ultrasound Maximizes Patient Satisfaction. J Emerg Med 2013. 
291. Lindelius A, Torngren S, Nilsson L, Pettersson H, Adami J. Randomized clinical trial 
of bedside ultrasound among patients with abdominal pain in the emergency department: 
impact on patient satisfaction and health care consumption. Scandinavian journal of 
trauma, resuscitation and emergency medicine 2009: 17: 60. 
292. Laursen CB, Sloth E, Lassen AT, Davidsen JR, Lambrechtsen J, Henriksen DP, Madsen 
PH, Rasmussen F. Does point-of-care ultrasonography cause discomfort in patients 
admitted with respiratory symptoms? Scandinavian journal of trauma, resuscitation and 
emergency medicine 2015: 23: 46. 
293. Krainin BM, Thaut LC, April MD, Curtis RA, Kaelin AL, Hardy GB, Weymouth WL, 
Srichandra J, Chin EJ, Summers SM. Heated Ultrasound Gel and Patient Satisfaction with 
Bedside Ultrasound Studies: The HUGS Trial. The western journal of emergency medicine 
2017: 18(6): 1061-1067. 
 
 
Figure 1. Normal findings and chest wall. A. Normal findings: The muscles, fascia and other soft tissues of 
the chest wall (CW) are located in the upper part of the image. The surfaces of the ribs (R) can be seen as 
two horizontal hyperechoic, white, lines with posterior “shadowing” (*). The pleuraline (P) is located just 
below the ribs. The lung tissue is filled with air and can therefore not be seen. The area (“L”) which can be 
seen below the pleuraline is therefore not the lung tissue but artefacts. B. Rib fracture: The surface of the 
rib (R) can be seen as a horizontal, hyperechoic white line. A rib fracture (F) is present. C. Subcutaneous 
emphysema: Air in the chest wall is typically seen as hyperechoic lines or dots with posterior shadowing (*). 
When the air is placed along a fascia it can be mistaken for the pleuraline. When compared to A, the ribs can 
however not be visualised and the hyperechoic white line caused by the subcutaneous emphysema is much 
more superficially located (approx. 1 cm) than the pleuraline seen in A (approx. 2.5 cm). D. Benign pleural 
tumor: A parietal pleural tumor is present (T). It is seen as a hypoechoic, black, well demarcated structure 
located above the pleuraline (P). 
Figure 2. Pleural effusion and pleural malignancy: A. Simple pleural effusion: A simple, anechoic, pleural 
effusion (E) is present. There are no septations or visible structures floating within the effusion. The effusion 
can be used as an acoustic window to visualise underlying structures such as the lung (L), diaphragm (D) 
and thoracic spine (S). Abdominal structures such as the spleen (A) can be visualized below the diaphragm. 
B. Malignant pleural effusion: Image from a patient with a malignant pleural effusion. A large nodule (N) is 
present on the diaphragm. Hyperechoic “plankton” (P) can be seen floating within the effusion. The 
compressed lung (L) and the liver (A) can also be seen. C. Complex septated pleural effusion: A complex 
septated pleural effusion is present, containing areas of anechoic fluid (F) as well as several septa (S). The 
heart (H) can be seen in the lower left side of the image.  D. Malignant pleural mesothelioma: A large 
malignant pleural mesothelioma (M) is present and seen as a relatively homogeneous structure, resembling 
that of the liver (A) placed below the diaphragm (D). Invasive growth (I) through the diaphragm and into 
the liver is present. 
Figure 3. Pneumothorax and B-lines: A. Normal M-mode findings: At the top of the image, the M-mode line 
can be seen as being placed vertically through the pleuraline (P). In the corresponding M-mode image the 
pleuraline is seen as a hyperechoic line placed at the same distance from the transducer as can be seen in 
the 2D image (approx. 1.8 cm). The non-moving structures of the chest wall can in the M-mode image be 
seen as horizontal lines (Se) above the pleura line. In the presence of lung sliding, the area below the 
pleuraline in the M-mode image will have a grainy appearance. The pattern has been described as 
resembling a seashore and is therefore also known as “seashore sign”. B. M-mode findings in 
pneumothorax: If lung sliding and lung pulse is absent, there will be no change in the area below the 
pleuraline in the 2D / B-mode image. When using M-mode this will be seen as horizontal lines (St) being 
present above and below the pleuraline (P). The M-mode pattern has been described as resembling a 
“barcode” or a “stratosphere” and is therefore also known as “barcode sign” or “stratosphere sign”. The sign 
can be seen when a pneumothorax is present, but also in other conditions with absence of lung sliding and 
pulse (e.g. pleural adhesions). C. Multiple B-lines: Multiple B-lines (B) can be seen as vertical, hyperechoic, 
lines originating in the pleuraline and stretching all the way from the pleuraline to the bottom of the 2D / B-
mode image. D. Idiopathic pulmonary fibrosis: TUS image of the lower lobe of a patient diagnosed with 
idiopathic pulmonary fibrosis. Multiple B-lines are present (B) and the pleuraline (P) appears severely 
thickened and fragmented. 
Figure 4. Consolidation and invasive procedures: A. Pneumonia: A lung consolidation is present (C). Air 
bronchograms (A) are present and can be seen as hyperechoic dots or lines within the consolidation. The 
border zone (B) to the air-filled parts of the lung tissue appear serrated and irregular. B-lines can often be 
seen in the area surrounding the consolidation. The sonomorphology is typical for a pneumonia. B. Lung 
tumor: A lung tumor (T) is present and can be seen as a rounded, well demarcated structure with a fairly 
homogenous, tissue-like appearance. Invasive growth (I) into the chest wall is present. C. US guided biopsy 
of a pleural tumor: A pleural tumor (T) can be seen superficial to the pleuraline (P). A needle has US guided 
been placed in the tumor in order to obtain a biopsy. The needle tip can be seen above the pleuraline, 
minimising the risk of pneumothorax. C. US guided biopsy of a lung tumor: A lung tumor (T) is present. A 
needle has US guided been placed in the tumor in order to obtain a biopsy. The needle tip has been placed 
in the margin of tumor but still with some distance to the normal air-filled lung. This has been done in order 
to avoid obtaining a biopsy from central necrotic areas of the lung and yet still attempting to minimise the 
risk of pneumothorax. 
Appendix: Search terms used for each statement topic 
The specific search terms used for each of the statement topics are given below. 
Equipment and technique: 
(Ultrasound OR ultrasonic OR echography OR sonographic OR sonography) AND (chest OR thoracic OR 
thorax OR lung OR lungs OR pulmonal) AND (protocol OR technique OR zone) 
Chest wall and parietal pleura: 
(Ultraso OR sonograph) AND (chest OR thoracic OR thorax) AND (rib OR "parietal pleura") 
Pleural effusion: 
(Ultraso OR sonograp OR echograp) AND (pleural OR thorax OR thoracic OR chest OR intrathoracic or 
endothoracic OR transthoracic) AND (fluid OR effusion OR liquid OR exudate OR transudate) 
Pneumothorax: 
(Ultrasound OR ultrasono) AND (pneumothorax OR pneumothor) 
Interstitial syndrome: 
(Ultrasound OR ultrasonic OR echography OR sonographic OR sonography) AND (chest OR thoracic OR 
thorax OR lung OR lungs OR pulmonal) AND (interstitial syndrome) 
Lung consolidation: 
(Ultrasound OR Ultrasonic OR echography OR sonographic OR sonography) AND (chest OR thoracic OR 
thorax OR lung OR lungs OR pulmonal) AND (consolidation OR pneumonia OR pulmonary embolism OR 
contusion OR atelectasis)  
Diaphragm: 
(Diaphragm) AND (ultrasound OR sonography) 
US guided procedures: 
(Ultrasound OR US) AND (guided) AND (intervention OR procedure OR thoracentesis OR 
chest drain OR indwelling pleural catheter OR biopsy OR thoracoscopy) AND (lung OR pleural 
OR thoracic OR chest) 
Training: 
(Ultrasound OR ultrasonic OR echography OR sonographic OR sonography) AND (chest OR thoracic OR 
thorax OR lung OR lungs OR pulmonal) AND (training OR education OR simulation OR (virtual reality) OR 
assessment OR test) 
Patient perspectives: 
((Ultrasound OR ultrasonography) AND (thorax OR respiratory OR lung OR chest) AND (patient) AND 
(preference OR experience OR satisfaction OR perspective) 
